{"chunk_type":"transcript_chunk","text":"| ì§ˆí™˜ (Condition) | í•µì‹¬ ë‹¨ì„œ (Key Clues & Keywords) | íŠ¹ì§•ì  ì†Œê²¬ (Pathognomonic Signs) |\n| --- | --- | --- |\n| **ê¸‰ì„± ì‹¬ì¥ë§‰ì—¼** | **ìì„¸ì— ë”°ë¥¸ í†µì¦ (Positional Pain)** | ëˆ•ìœ¼ë©´ ì•…í™” â¬†ï¸, ìˆ™ì´ë©´ ì™„í™” â¬‡ï¸ (ë§ˆì°°ìŒ Friction rub) |\n| **í˜‘ì°©ì„± ì‹¬ì¥ë§‰ì—¼** | **ê°‘ì˜· ì‹¬ì¥ (Armor Heart)** | **ì‹¬ì¥ë§‰ ë…¸í¬ìŒ (Pericardial Knock)**, ìš°ì‹¬ë¶€ì „(ë³µìˆ˜, ë¶€ì¢…) |\n| **ì‹¬ê·¼ì—¼** | **ì Šì€ í™˜ì + ê°ê¸°(Viral) í›„ ì‹¬ë¶€ì „** | **Friendly Fire** (ë©´ì—­ ë°˜ì‘), ì‹¬ì‹¤ í™•ì¥ |\n| **ì‹¬ì¥ ëˆŒë¦¼ì¦** | **ì••ë ¥ í‰ì¤€í™” (Equalization)** | **ê¸°ì´ë§¥ (Pulsus Paradoxus)**, **ì „ê¸°ì  êµëŒ€ë§¥ (Electrical Alternans)**, Water bottle heart |\n- **Action for Tamponade:** ì‘ê¸‰ ì‹¬ì¥ë§‰ ì²œììˆ  (Pericardiocentesis) â˜…\nì œê³µí•´ì£¼ì‹  ì˜¤ë””ì˜¤ íŒŒì¼(13 drugs.m4a)ì„ ë°”íƒ•ìœ¼ë¡œ USMLE Step 2 ëŒ€ë¹„ ì‹¬í˜ˆê´€ê³„ ì•½ë¬¼ ê°•ì˜ë¡ì„ ì‘ì„±í–ˆìŠµë‹ˆë‹¤. ì´ ê°•ì˜ë¡ì€ **Internal Knowledgeë¥¼ ë°°ì œí•˜ê³  ì˜¤ì§ ì˜¤ë””ì˜¤ ë‚´ìš©ë§Œì„ ê¸°ë°˜ìœ¼ë¡œ** ì‘ì„±ë˜ì—ˆìœ¼ë©°, ì„ìƒì  ì‹œë‚˜ë¦¬ì˜¤ì™€ ì£¼ì˜ì‚¬í•­ì„ ë¹ ì§ì—†ì´ í¬í•¨í–ˆìŠµë‹ˆë‹¤.\n---\n\"USMLE Step 2 ì‹œí—˜ ì¤€ë¹„í•˜ê³  ê³„ì‹œëŠ”êµ°ìš”. ì•„ ë³´ë‚´ì£¼ì‹  ìë£Œ ë³´ë‹ˆê¹Œ ì‹¬í˜ˆê´€ê³„ ì•½ë¬¼ íŒŒíŠ¸, ì´ê±° ì •ë§ ë§Œë§Œì¹˜ ì•Šì£ . ê³ í˜ˆì••, ì‹¬ë¶€ì „, ê´€ìƒë™ë§¥ì§ˆí™˜... ì–´ ì „ë¶€ ë‹¤ë¥¸ ë³‘ì¸ë°, ACE ì–µì œì œ, ë² íƒ€ ì°¨ë‹¨ì œ ê°™ì€ ì•½ë“¤ì€ ê³„ì† ì¤‘ë³µí•´ì„œ ë‚˜ì˜¤ì–ì•„ìš”. ê·¸ëŸ¬ë‹¤ ë³´ë‹ˆê¹Œ, ì–´? ì´ ì•½ì´ ì €ê¸°ì„œë„ ì“°ì˜€ë‚˜? í•˜ê³  ë§‰ í—·ê°ˆë¦¬ê¸° ì‹œì‘í•˜ì£ .\"\n---\n# ğŸ’Š USMLE Step 2 ì‹¬í˜ˆê´€ê³„ ì•½ë¬¼ ì™„ì „ ì •ë³µ: ê°™ì€ ì•½, ë‹¤ë¥¸ ì—­í•  (Hero vs. Villain)\n## 1. Introduction: ì•½ë¬¼ í˜¼ë€ì˜ ì›ì¸ê³¼ í•´ê²°ì±…\n- **ë¬¸ì œì :** ê³ í˜ˆì••, ì‹¬ë¶€ì „, ê´€ìƒë™ë§¥ì§ˆí™˜ ë“± ì§ˆë³‘ì€ ë‹¤ë¥¸ë°, ë“±ì¥í•˜ëŠ” ì•½ë¬¼(ACEi, Beta-blocker ë“±)ì€ ê³„ì† ê²¹ì³ì„œ í—·ê°ˆë¦¼.\n- **í•µì‹¬ í¬ì¸íŠ¸:** ìƒí™©(Context)ì— ë”°ë¼ ìƒëª…ì„ êµ¬í•˜ëŠ” **í•„ìˆ˜ ì•½(Hero)**ì´ ë˜ê¸°ë„ í•˜ê³ , í™˜ìë¥¼ ìœ„í—˜ì— ë¹ ëœ¨ë¦¬ëŠ” **ì ˆëŒ€ ê¸ˆê¸°(Villain)**ê°€ ë˜ê¸°ë„ í•¨.\n- **í•´ê²°ì±…:** 'ë™ë°˜ ì§ˆí™˜(Compelling Indication)'ì„ í†µí•´ ì•½ë¬¼ ì„ íƒì˜ ìš°ì„ ìˆœìœ„ë¥¼ ì •í•˜ê³ , ê° ì§ˆë³‘ ë¬´ëŒ€ì—ì„œ ì•½ë¬¼ì˜ ì—­í•  ë³€í™”ë¥¼ ì´í•´í•´ì•¼ í•¨.\n---\n## 2. ê³ í˜ˆì••(Hypertension): í™˜ìê°€ ëˆ„êµ¬ëƒì— ë”°ë¼ ë„êµ¬ê°€ ë°”ë€ë‹¤\nê³ í˜ˆì•• ì¹˜ë£Œì˜ ê¸°ë³¸ ë„êµ¬ëŠ” 4ê°€ì§€(ACEi, ARB, CCB, Thiazide)ì§€ë§Œ, **í™˜ìì˜ ë™ë°˜ ì§ˆí™˜**ì´ ë¬´ì—‡ì„ ë¨¼ì € êº¼ë‚¼ì§€ ê²°ì •í•¨.\n### 2-1. ë§Œì„± ì‹ ì¥ ì§ˆí™˜ (CKD) í™˜ì\n- **Best Choice:** â˜… **ACE ì–µì œì œ (ACEi) ë˜ëŠ” ARB**\n- **ì´ìœ  (Mechanism):** ë‹¨ìˆœíˆ í˜ˆì••ë§Œ ë‚®ì¶”ëŠ” ê²ƒì´ ì•„ë‹˜.\n- ì‹ ì¥ì˜ í•„í„° ì—­í• ì¸ ì‚¬êµ¬ì²´ì—ëŠ” ë“¤ì–´ì˜¤ëŠ” í˜ˆê´€(ìˆ˜ì…ì„¸ë™ë§¥)ê³¼ ë‚˜ê°€ëŠ” í˜ˆê´€(ìˆ˜ì¶œì„¸ë™ë§¥)ì´ ìˆìŒ.\n- ì´ ì•½ë“¤ì€ **ìˆ˜ì¶œì„¸ë™ë§¥(ë‚˜ê°€ëŠ” ê¸¸)ì„ ì´ì™„**ì‹œí‚´ â†’ ë‚˜ê°€ëŠ” ê¸¸ì´ ë„“ì–´ì§€ë‹ˆ ì‚¬êµ¬ì²´ ë‚´ ì••ë ¥ì´ ë‚®ì•„ì§.\n- **ê²°ê³¼:** í•„í„° ì†ìƒì„ ë§‰ê³  ë‹¨ë°±ë‡¨ë¥¼ ì¤„ì—¬ ì‹ ì¥ ê¸°ëŠ¥ ì•…í™”ë¥¼ ëŠ¦ì¶¤ (ì‹ ì¥ ë³´í˜¸ íš¨ê³¼).\n- **ì‹œí—˜ í¬ì¸íŠ¸:** ë‹¹ë‡¨ë³‘ì´ë‚˜ ë‹¨ë°±ë‡¨ê°€ ìˆëŠ” CKD í™˜ìëŠ” ë¬´ì¡°ê±´ ACEi/ARBë¥¼ ë– ì˜¬ë ¤ì•¼ í•¨.\n### 2-2. í†µí’ (Gout) vs. ê³¨ë‹¤ê³µì¦ (Osteoporosis) í™˜ì\nê°™ì€ ì´ë‡¨ì œ(Thiazide)ë¼ë„ í™˜ìì— ë”°ë¼ ë…ì´ ë˜ê±°ë‚˜ ì•½ì´ ë¨.\n| ìƒí™© | í™˜ì | Thiazideì˜ ì—­í•  | ì´ìœ  |\n| --- | --- | --- | --- |\n| **Villain** ğŸ˜ˆ | **í†µí’ (Gout)** | **í”¼í•´ì•¼ í•¨ (ê¸ˆê¸°)** | ë¶€ì‘ìš©ìœ¼ë¡œ í˜ˆì¤‘ ìš”ì‚° ìˆ˜ì¹˜ë¥¼ ë†’ì„. (ë¶ˆë‚œ ì§‘ì— ë§ˆë¥¸ ì¥ì‘ ë˜ì§€ëŠ” ê²©) |\n| **Hero** ğŸ˜‡ | **ê³¨ë‹¤ê³µì¦** | **ì¶”ì²œë¨ (Strongly Indicated)** | ì‹ ì¥ì—ì„œ ì¹¼ìŠ˜ì´ ì†Œë³€ìœ¼ë¡œ ë¹ ì ¸ë‚˜ê°€ëŠ” ê²ƒì„ ë§‰ê³  ì¬í¡ìˆ˜ ì´‰ì§„ â†’ í˜ˆì¤‘ ì¹¼ìŠ˜ ë†ë„ ìœ ì§€ ë³´ì¡°. (ì¼ì„ì´ì¡°) |\n## 3. ê¸‰ì„± ê´€ìƒë™ë§¥ ì¦í›„êµ° (ACS/MI): ì‹¬ì¥ì„ ì‰¬ê²Œ í•˜ë¼","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-190","focus_area":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","tags":["usmle-step2","core","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"ì‘ê¸‰ì‹¤ì— ì‹¤ë ¤ ì˜¨ ì‹¬ê·¼ê²½ìƒ‰ í™˜ì ìƒí™©. ëª©í‘œëŠ” **ì‹¬ì¥ ê·¼ìœ¡ ì‚´ë¦¬ê¸°**.\n### 3-1. ë² íƒ€ ì°¨ë‹¨ì œ (Beta-blocker)\n- **ì—­í•  (Hero):** ì‹¬ì¥ì„ ëŠë¦¬ê²Œ ë›°ê²Œ í•˜ê³  ìˆ˜ì¶•ë ¥ì„ ì¤„ì—¬ **'ê°•ì œ íœ´ì‹'**ì„ ì¤Œ.\n- ì‚°ì†Œ ìš”êµ¬ëŸ‰ ê°ì†Œ â†’ ì‹¬ê·¼ ì†ìƒ ë²”ìœ„ ì¶•ì†Œ.\n- ì¹˜ëª…ì ì¸ ë¶€ì •ë§¥ ì˜ˆë°©.\n- **â˜… ì ˆëŒ€ ê¸ˆê¸° (Trap):** ì‹¬ì¸ì„± ì‡¼í¬(Cardiogenic Shock), ì„œë§¥, ì €í˜ˆì••ì´ ìˆëŠ” ê²½ìš°.\n- ì´ë¯¸ êº¼ì ¸ê°€ëŠ” ë¶ˆ(ì‹¬ì¥)ì— ì°¬ë¬¼ì„ ë¼ì–¹ëŠ” ê²ƒê³¼ ê°™ìŒ. ì‹¬ì¥ì„ ì™„ì „íˆ ë©ˆì¶”ê²Œ í•  ìˆ˜ ìˆì–´ ìœ„í—˜í•¨.\n- **Action:** í™˜ìì˜ **í˜ˆì••ê³¼ ë§¥ë°•**ì„ ê°€ì¥ ë¨¼ì € í™•ì¸í•´ì•¼ í•¨.\n### 3-2. ì§ˆì‚°ì—¼ (Nitrates)\n- **ì—­í• :** í˜ˆê´€ í™•ì¥ â†’ ì‹¬ì¥ìœ¼ë¡œ ëŒì•„ì˜¤ëŠ” í”¼(ì „ë¶€í•˜, Preload) ê°ì†Œ & ê´€ìƒë™ë§¥ í™•ì¥ â†’ í‰í†µ ì™„í™”.\n- **â˜… ì£¼ì˜ (Trap):** **ìš°ì‹¬ì‹¤ ê²½ìƒ‰ (Right Ventricular Infarction)**\n- ìš°ì‹¬ì‹¤ì€ ì „ì‹ ì—ì„œ ë“¤ì–´ì˜¤ëŠ” í˜ˆì•¡ëŸ‰(ì „ë¶€í•˜)ì— ë§¤ìš° ì˜ì¡´ì ì„.\n- ì§ˆì‚°ì—¼ìœ¼ë¡œ ì „ë¶€í•˜ë¥¼ í™• ë–¨ì–´ëœ¨ë¦¬ë©´ ì‹¬ì¥ì´ í”¼ë¥¼ ì§œë‚´ì§€ ëª»í•´ ì‹¬ê°í•œ ì €í˜ˆì••(Shock) ë°œìƒ ê°€ëŠ¥.\n### 3-3. ì¥ê¸°ì  ê´€ë¦¬: ACE ì–µì œì œ & ARB\n- **ì—­í•  (Architect):** **ì‹¬ì¥ ë¦¬ëª¨ë¸ë§(Remodeling) ë°©ì§€**.\n- ì‹¬ê·¼ê²½ìƒ‰ í›„ ìƒì²˜ê°€ ì•„ë¬¼ë©´ì„œ ì‹¬ì¥ ëª¨ì–‘ì´ ë³€í˜•(í’ì„ ì²˜ëŸ¼ ëŠ˜ì–´ë‚¨)ë˜ëŠ” ê²ƒì„ ë§‰ì•„ì¤Œ.\n- ë‹¨ê¸° ìˆ˜ë¦¬ê°€ ì•„ë‹Œ ì¥ê¸°ì ì¸ ì‹¬ë¶€ì „ ì˜ˆë°©ì„ ìœ„í•´ í•„ìˆ˜.\n---\n## 4. ì‹¬ë¶€ì „ (Heart Failure): íƒ€ì´ë°ì˜ ì˜ˆìˆ \nì‹¬ë¶€ì „ì€ **ê¸‰ì„±ê¸°(Acute)**ì™€ **ë§Œì„±ê¸°(Chronic)**ì˜ ì¹˜ë£Œ ì „ëµì´ ì •ë°˜ëŒ€ì„.\n### 4-1. ê¸‰ì„± ì•…í™”ê¸° (Acute Decompensated HF) - \"Cold & Wet\"\n- í™˜ì ìƒíƒœ: ìˆ¨ì´ ì°¨ê³ (íë¶€ì¢…), ë¶“ê³ , í˜ˆì••ì´ ë–¨ì–´ì§ˆ ìˆ˜ ìˆìŒ.\n- **â˜… Beta-blocker ê¸ˆê¸°:** ìˆ¨ì´ ë„˜ì–´ê°€ëŠ” í™˜ìì—ê²Œ ì‹¬ì¥ì„ ì²œì²œíˆ ë›°ê²Œ í•˜ëŠ” ê±´ **\"ì§€ì¹œ ë§ì—ê²Œ ì±„ì°ì§ˆì„ ë©ˆì¶”ê³  ë°¥ì„ êµ¶ê¸°ëŠ” ê²ƒ\"**ê³¼ ê°™ìŒ (ì˜¤íˆë ¤ ì•…í™”).\n- ë§Œì•½ í™˜ìê°€ ê¸°ì¡´ì— ë² íƒ€ ì°¨ë‹¨ì œë¥¼ ë¨¹ê³  ìˆì—ˆë‹¤ë©´? ìš©ëŸ‰ì„ ì¤„ì´ê±°ë‚˜ ì ì‹œ ëŠì–´ì•¼ í•¨.\n- **ì¹˜ë£Œ:** **ì´ë‡¨ì œ (Loop Diuretic - Furosemide)** ë“±ìœ¼ë¡œ ë¬¼ì„ ë¹¼ì¤˜ì„œ ì¦ìƒì„ ì¡°ì ˆí•˜ëŠ” ê²ƒì´ ìš°ì„ .\n### 4-2. ë§Œì„± ì•ˆì •ê¸° (Chronic HFrEF)\ní™˜ìê°€ ê¸‰ì„±ê¸°ë¥¼ ë„˜ê¸°ê³  í‡´ì› í›„ ì™¸ë˜ë¥¼ ë‹¤ë‹ ë•Œ. ëª©í‘œëŠ” **ìƒì¡´ìœ¨ ì¦ê°€(Mortality Benefit)**.\n- **í•„ìˆ˜ ì•½ë¬¼ 4ì´ì‚¬ (Fantastic Four):**\n1. **Beta-blocker:** êµê°ì‹ ê²½ì˜ ê³¼ë„í•œ ë…ì„±(ì±„ì°ì§ˆ)ìœ¼ë¡œë¶€í„° ì‹¬ì¥ì„ ë³´í˜¸. ì¥ê¸°ì ìœ¼ë¡œ ìƒì¡´ìœ¨ ë†’ì„.\n2. **ACEi / ARB / ARNI:** ì‹¬ì¥ ë¦¬ëª¨ë¸ë§ ë°©ì§€.\n3. **MRA (Spironolactone):** ì•Œë„ìŠ¤í…Œë¡  ê¸¸í•­ì œ.\n4. **SGLT2 ì–µì œì œ:** ìµœì‹  íŠ¸ë Œë“œ. ë‹¹ë‡¨ ìœ ë¬´ì™€ ìƒê´€ì—†ì´ ì‹¬ë¶€ì „ ì‚¬ë§ë¥  ê°ì†Œ ì…ì¦.\n- **â˜… ì£¼ì˜ (Trap):** ì‹¬ë¶€ì „(HFrEF) í™˜ìì—ê²Œ **Non-DHP CCB (Verapamil, Diltiazem)**ëŠ” ê¸ˆê¸°.\n- ì‹¬ì¥ ìˆ˜ì¶•ë ¥ì„ ì§ì ‘ì ìœ¼ë¡œ ë–¨ì–´ëœ¨ë¦¬ëŠ”(ìŒì„± ë³€ë ¥ ì‘ìš©) íš¨ê³¼ê°€ ìˆì–´ ì‹¬ë¶€ì „ì„ ì•…í™”ì‹œí‚´.\n---\n## 5. ì¸ì²´ì˜ ë³´ìƒ ê¸°ì „ê³¼ ì•½ë¬¼ ì¡°í•© (Deep Dive)\nì•½ë¬¼ì„ ì¼ì„ ë•Œ ìš°ë¦¬ ëª¸ì´ ê°€ë§Œíˆ ìˆì§€ ì•Šê³  ë°˜ê²©(ë³´ìƒ ê¸°ì „)ì„ í•¨.\n- **ì´ë‡¨ì œ ì‚¬ìš© ì‹œ:**\n- ëª¸ì—ì„œ ìˆ˜ë¶„/ì—¼ë¶„ì„ ê°•ì œë¡œ ë¹¼ë©´ â†’ ëª¸ì€ \"ì–´? íƒˆìˆ˜ë„¤? í˜ˆì•• ë†’ì—¬ì•¼ì§€!\" í•˜ê³  **RAAS (ë ˆë‹Œ-ì•ˆì§€ì˜¤í…ì‹ -ì•Œë„ìŠ¤í…Œë¡ ) ì‹œìŠ¤í…œ**ì„ í’€ê°€ë™í•¨.\n- **ì•½ë¬¼ ê¿€ì¡°í•© (Synergy):**\n- **ì´ë‡¨ì œ + ACEi/ARB ë³‘ìš©:** ì´ë‡¨ì œë¡œ ì¸í•œ RAAS ì‹œìŠ¤í…œì˜ ë°˜ê²©(í˜ˆì•• ìƒìŠ¹ ì‹œë„)ì„ ACEiê°€ ì°¨ë‹¨í•¨.\n- ì„œë¡œì˜ ì•½ì ì„ ë³´ì™„í•˜ë©° ë” ê°•ë ¥í•œ íš¨ê³¼ë¥¼ ëƒ„.\n---","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-210","focus_area":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","tags":["usmle-step2","core"]}
{"chunk_type":"recap_summary","text":"## ğŸ”¥ Rapid Fire Recap: Must-Know High Yield Summary\nì‹œí—˜ ì§ì „ ì´ê²ƒë§Œì€ ê¼­ ê¸°ì–µí•˜ì„¸ìš”!\n1. **CKD + ê³ í˜ˆì••** â†’ **ACEi / ARB** (ìˆ˜ì¶œì„¸ë™ë§¥ ì´ì™„, ì‹ ì¥ ë³´í˜¸)\n2. **í†µí’ + ê³ í˜ˆì••** â†’ **Thiazide ê¸ˆê¸°** (ìš”ì‚° ì¦ê°€)\n3. **ê³¨ë‹¤ê³µì¦ + ê³ í˜ˆì••** â†’ **Thiazide ì¶”ì²œ** (ì¹¼ìŠ˜ ì¬í¡ìˆ˜, ë¼ˆ ë³´í˜¸)\n4. **ê¸‰ì„± ì‹¬ê·¼ê²½ìƒ‰(ACS)** â†’ **Beta-blocker** (ì‹¬ì¥ íœ´ì‹, Hero)\n- â˜… **ì˜ˆì™¸:** ì„œë§¥, ì €í˜ˆì••, ì‹¬ì¸ì„± ì‡¼í¬ ë•ŒëŠ” **ê¸ˆê¸°** (Villain).\n1. **ìš°ì‹¬ì‹¤ ê²½ìƒ‰ (RV MI)** â†’ **Nitrates ì£¼ì˜/ê¸ˆê¸°** (ì „ë¶€í•˜ ê°ì†Œë¡œ ì‡¼í¬ ìœ ë°œ)\n2. **ê¸‰ì„± ì‹¬ë¶€ì „ (ìˆ¨ ì°¨ê³  ë¶€ìŒ)** â†’ **Beta-blocker ì¤‘ë‹¨/ê¸ˆê¸°** (ì¦ìƒ ì•…í™”)\n3. **ë§Œì„± ì‹¬ë¶€ì „ (HFrEF)** â†’ **Beta-blocker + ACEi/ARNI + MRA + SGLT2i** (ìƒì¡´ìœ¨ ì¦ê°€, ì‚¬ë§ë¥  ê°ì†Œ)\n- â˜… **Non-DHP CCB (Verapamil/Diltiazem)** â†’ **ì‹¬ë¶€ì „ì—ì„œ ì ˆëŒ€ ê¸ˆê¸°** (ì‹¬ì¥ ìˆ˜ì¶•ë ¥ ì €í•˜)\n**Host 1:** \"USMLE Step 2 ì¤€ë¹„ì— í•œì°½ì´ì‹¤ ì—¬ëŸ¬ë¶„ì„ ìœ„í•´ ì˜¤ëŠ˜ ì•„ì£¼ í¥ë¯¸ë¡œìš´ ìë£Œë“¤ì„ ë¶„ì„í•´ ë³´ë ¤ê³  í•©ë‹ˆë‹¤.\"\n**Host 2:** \"ë„¤.\"\n**Host 1:** \"ë³´ë‚´ì£¼ì‹  ìë£Œë“¤ì„ ë³´ë‹ˆê¹Œìš”, ì‹¬í˜ˆê´€ê³„ íŒŒíŠ¸ì—ì„œ ê¸°íƒ€ë¡œ ë¶„ë¥˜ëœ... ì–´ ë­ë„ê¹Œ ì„œë¡œ ì¢€ ìƒê´€ì—†ì–´ ë³´ì´ëŠ” ê°œë…ë“¤ ëª¨ìŒì´ë”ë¼ê³ ìš”.\"\n**Host 2:** \"ë§ìŠµë‹ˆë‹¤.\"\n**Host 1:** \"ì‹¤ì‹ , ë­ ê¸°ì´í•œ ì´ë¦„ì˜ ë§¥ë°•, í¬ê·€ ìœ ì „ë³‘, ì¸ê³µ íŒë§‰ ë¬¸ì œê¹Œì§€...\"\n**Host 2:** \"ë„¤ë„¤.\"\n**Host 1:** \"ê·¸ë˜ì„œ ì˜¤ëŠ˜ì˜ ë¯¸ì…˜ì€ ì´ í©ì–´ì ¸ ìˆëŠ” ì§€ì‹ ì¡°ê°ë“¤ ì†ì— ìˆ¨ê²¨ì§„ ê·¸ ì—°ê²°ê³ ë¦¬ë¥¼ ì°¾ì•„ì„œ í•˜ë‚˜ì˜ í†µí•©ëœ ê·¸ë¦¼ìœ¼ë¡œ ë¨¸ë¦¿ì†ì— ê°ì¸ì‹œì¼œ ë“œë¦¬ëŠ” ê²ë‹ˆë‹¤.\"\n---\n# ğŸ«€ USMLE Cardiology: \"Miscellaneous\" Concepts Integration\n## 1. Introduction: ì˜¤ëŠ˜ì˜ ë¯¸ì…˜ ğŸ¯\n- **ëª©í‘œ:** ì‹¬í˜ˆê´€ê³„ì—ì„œ 'ê¸°íƒ€(Miscellaneous)'ë¡œ ë¶„ë¥˜ë˜ì–´ ì„œë¡œ ìƒê´€ì—†ì–´ ë³´ì´ëŠ” ê°œë…ë“¤(ì‹¤ì‹ , í¬ê·€ ìœ ì „ë³‘, ì¸ê³µ êµ¬ì¡°ë¬¼ ë“±)ì˜ ìˆ¨ê²¨ì§„ **ì—°ê²°ê³ ë¦¬**ë¥¼ ì°¾ì•„ í†µí•©ëœ ê·¸ë¦¼ìœ¼ë¡œ ì´í•´í•˜ê¸°.\n- **ì ‘ê·¼ë²•:** í©ì–´ì ¸ ìˆëŠ” ì§€ì‹ ì¡°ê°ë“¤ì„ í•˜ë‚˜ì˜ ìŠ¤í† ë¦¬ë¡œ ì—°ê²°í•˜ì—¬ ì‹œí—˜ì—ì„œì˜ ë³€ë³„ë ¥ì„ ê°€ë¥´ëŠ” 'í•œ ë—'ì„ ì™„ì„±í•¨.\n- **í•µì‹¬ ì£¼ì œ:** ë°˜ë³µë˜ëŠ” ì½”í”¼ì™€ ë‡Œë†ì–‘ì˜ ê´€ê³„, ìŠ¤íŠ¸ë ˆìŠ¤ì„± ì‹¤ì‹ ê³¼ ìƒë¦¬ì  ê¸°ì „ ë“± ì„ìƒì  ì‹œë‚˜ë¦¬ì˜¤ë¥¼ í†µí•œ ì—°ê²°.\n## 2. ì‹¤ì‹  (Syncope): ë¯¸ì£¼ì‹ ê²½ì„± vs. êµ¬ì¡°ì  ë¬¸ì œ ğŸ§ ğŸ’”","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-230","focus_area":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","tags":["usmle-step2","core","recap"]}
{"chunk_type":"transcript_chunk","text":"### A. í˜ˆê´€ë¯¸ì£¼ì‹ ê²½ì„± ì‹¤ì‹  (Vasovagal Syncope)\n- **ì •ì˜:** ìŠ¤íŠ¸ë ˆìŠ¤ë¥¼ ë°›ê±°ë‚˜ ì˜¤ë˜ ì„œ ìˆì„ ë•Œ ë°œìƒí•˜ëŠ” ì‹¤ì‹ . ë‹¨ìˆœ ì‹¬ë¦¬ì  ë¬¸ì œê°€ ì•„ë‹Œ **ëšœë ·í•œ ìƒë¦¬í•™ì  ê¸°ì „**ì´ ìˆìŒ.\n- **ê¸°ì „ (Mechanism):** â˜… **'ë¯¸ì£¼ì‹ ê²½ì˜ ì—­ì„¤ì  ê³¼í™œì„±í™” (Paradoxical Overactivation)'**\n1. ê·¹ì‹¬í•œ ìŠ¤íŠ¸ë ˆìŠ¤/í†µì¦/ì˜¤ë˜ ì„œ ìˆìŒ (íŠ¹ì • ìê·¹).\n2. êµê°ì‹ ê²½ì´ í¥ë¶„í–ˆë‹¤ê°€, ê°‘ìê¸° **ë¯¸ì£¼ì‹ ê²½(ë¶€êµê°)ì´ ê³¼ë„í•˜ê²Œ ë°œë™(í™•!)**.\n3. ì‹¬ë°•ìˆ˜ ì €í•˜(Bradycardia) + í˜ˆê´€ í™•ì¥(Vasodilation).\n4. í˜ˆì••ê³¼ ì„œë§¥ì˜ ì´ì¤‘ íƒ€ê²© ë‡Œë¡œ ê°€ëŠ” í˜ˆë¥˜ ì…§ë‹¤ìš´ (ë‡Œì˜ ìê¸° ë³´í˜¸ ê¸°ì „).\n- **ì¹˜ë£Œ/ëŒ€ì²˜ë²•:** â˜… **ë¬¼ë¦¬ì  ì €í•­ ìš´ë™ (Physical Counterpressure Maneuvers)**\n- **ë°©ë²•:** ë‹¤ë¦¬ë¥¼ ê¼¬ê³  í—ˆë²…ì§€/ì—‰ë©ì´ì— í˜ ë¹¡ ì£¼ê¸°, ì–‘ì† ê¹ì§€ ë¼ê³  ë‹¹ê¸°ê¸°.\n- **ì›ë¦¬:** ê·¼ìœ¡ ìˆ˜ì¶• ë‹¤ë¦¬ ì •ë§¥ì— ê³ ì¸ í”¼ë¥¼ ì‹¬ì¥ìœ¼ë¡œ ì§œì¤Œ(Pump ì—­í• ) ì‹¬ë°•ì¶œëŸ‰ ì¦ê°€ ë‡Œí˜ˆë¥˜ ìœ ì§€.\n- **Key Point:** ì•½ë¬¼ì´ë‚˜ ë§‰ì—°í•œ ì¡°ì–¸ì´ ì•„ë‹Œ, í™˜ìê°€ **ì „ì¡°ì¦ìƒ(Prodrome)**ì„ ëŠë‚„ ë•Œ ìŠ¤ìŠ¤ë¡œ í•  ìˆ˜ ìˆëŠ” ì¦‰ê°ì ì¸ ë¬¼ë¦¬ì  ì²˜ì¹˜ì„.\n### B. ìš´ë™ ì¤‘ ì‹¤ì‹ : AAOCA (Anomalous Aortic Origin of a Coronary Artery)\n- **ì‹œë‚˜ë¦¬ì˜¤:** **ê±´ê°•í•œ ì Šì€ ìš´ë™ì„ ìˆ˜**ê°€ ê²½ê¸° ì¤‘ ì „ë ¥ ì§ˆì£¼í•˜ë‹¤ê°€ ê°‘ìê¸° í”½ ì“°ëŸ¬ì§€ê±°ë‚˜ ì‚¬ë§(Sudden Cardiac Death).\n- **ì›ì¸:** ê´€ìƒë™ë§¥ì˜ ê¸°ì‹œë¶€ ì´ìƒ. ê´€ìƒë™ë§¥ì´ ëŒ€ë™ë§¥(Aorta)ê³¼ íë™ë§¥(Pulmonary Artery) ì‚¬ì´ì— ë¼ì–´ ìˆìŒ.\n- **ë¹„ìœ  (Analogy):** ğŸˆ **ë‘ ê°œì˜ ì»¤ë‹¤ë€ í’ì„ (ëŒ€ë™ë§¥, íë™ë§¥) ì‚¬ì´ì— ë‚€ ì •ì› í˜¸ìŠ¤(ê´€ìƒë™ë§¥).**\n- **ê¸°ì „:**\n1. í‰ì†Œì—ëŠ” ê´œì°®ìŒ.\n2. ìš´ë™ ì‹¬ë°•ì¶œëŸ‰ ì¦ê°€ ëŒ€ë™ë§¥ê³¼ íë™ë§¥ì´ í’ì„ ì²˜ëŸ¼ ë¶€í’€ì–´ ì˜¤ë¦„.\n3. ê·¸ ì‚¬ì´ì— ë‚€ ê´€ìƒë™ë§¥ í˜¸ìŠ¤ê°€ ê½‰ ëˆŒë¦¼.\n4. ì‹¬ì¥ì— í”¼ ê³µê¸‰ ì¤‘ë‹¨ ì‹¬ê·¼ í—ˆí˜ˆ ì¹˜ëª…ì  ë¶€ì •ë§¥/ê¸‰ì‚¬.\n- **ì£¼ì˜ì :** ì Šì€ í™˜ìì˜ **ìš´ë™ ì¤‘(Exertional)** ì‹¤ì‹ ì€ ì ˆëŒ€ ê°€ë³ê²Œ ë„˜ê¸°ë©´ ì•ˆ ë˜ëŠ” **Red Flag** ğŸš©.\n---\n## 3. ì••ë ¥ê³¼ ì†Œë¦¬ì˜ ì—­ì„¤: Cardiac Tamponade & Pulsus Paradoxus ğŸ“‰\n### A. ê¸°ì´ë§¥ (Pulsus Paradoxus)\n- **ì •ì˜:** ìˆ¨ì„ ê¹Šê²Œ ë“¤ì´ë§ˆì‹¤ ë•Œ ìˆ˜ì¶•ê¸° í˜ˆì••ì´ **10mmHg ì´ìƒ** ë–¨ì–´ì§€ëŠ” í˜„ìƒ.\n- **ì´ë¦„ì˜ ìœ ë˜:** ë§¥ë°•ì€ ë§Œì ¸ì§€ëŠ”ë° ì²­ì§„ê¸°ë¡œ ì‹¬ìŒì´ ì˜ ì•ˆ ë“¤ë¦¬ê±°ë‚˜ í˜ˆì••ì´ ëš ë–¨ì–´ì§€ëŠ” 'ì—­ì„¤ì ' ìƒí™©.\n- **ê¸°ì „:**\n1. í¡ê¸° ì‹œ í‰ê°• ë‚´ ì••ë ¥ ê°ì†Œ ìš°ì‹¬ì‹¤(RV)ë¡œ í”¼ê°€ ë§ì´ ë“¤ì–´ì˜´.\n2. ì‹¬ë‚­ì— ë¬¼ì´ ì°¨ ìˆì–´ ì‹¬ì¥ì´ ë°–ìœ¼ë¡œ ëª» ëŠ˜ì–´ë‚¨.\n3. ìš°ì‹¬ì‹¤ì´ ì»¤ì§€ëŠ” ëŒ€ì‹  **ì‹¬ì‹¤ ì¤‘ê²©(Septum)ì´ ì¢Œì‹¬ì‹¤(LV) ìª½ìœ¼ë¡œ ë°€ë ¤ë“¤ì–´ì˜´ (Interventricular Dependence).**\n4. ì¢Œì‹¬ì‹¤ ê³µê°„ ë¶€ì¡± ì‹¬ë°•ì¶œëŸ‰ ê°ì†Œ í˜ˆì•• ì €í•˜.\n### B. ì‹¬ì¥ ëˆŒë¦¼ì¦ (Cardiac Tamponade)\n- **ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤:** ëŒ€ë™ë§¥ ë°•ë¦¬ í™˜ì ë“±ì´ ê°‘ìê¸° í˜ˆì•• ì €í•˜, ê²½ì •ë§¥ í™•ì¥ ë“±ì„ ë³´ì„.\n- **â˜… Beck's Triad (ë²¡ì˜ 3ì§•í›„):**\n1. **ì €í˜ˆì•• (Hypotension):** íŒí”„ ê¸°ëŠ¥ ì‹¤íŒ¨.\n2. **ê²½ì •ë§¥ í™•ì¥ (JVD):** ì‹¬ì¥ìœ¼ë¡œ í”¼ê°€ ëª» ë“¤ì–´ê°€ì„œ ìƒê¸°ëŠ” Traffic Jam (ì••ë ¥ê³„ ì—­í• ).\n3. **ì‹¬ìŒ ê°ì†Œ (Muffled Heart Sounds):** ì‹¬ì¥ ì£¼ë³€ì˜ ë¬¼(í”¼) ë•Œë¬¸ì— ì†Œë¦¬ê°€ ë¨¹ë¨¹í•´ì§.\n- **ì§„ë‹¨:** Beck's Triad + ê¸°ì´ë§¥(Pulsus Paradoxus).\n- **ë¹„ìœ :** ì‹¬ë‚­ì´ë¼ëŠ” ì£¼ë¨¸ë‹ˆ ì•ˆì— í”¼ê°€ ì°¨ì„œ ì‹¬ì¥ì„ ê½‰ ì¡°ì´ëŠ” ìƒíƒœ.\n---\n## 4. ì¸ê³µ êµ¬ì¡°ë¬¼ì˜ ìœ„í—˜: ìŠ¤í…íŠ¸ì™€ íŒë§‰ ğŸ”©\n### A. ìŠ¤í…íŠ¸ í˜ˆì „ì¦ (Stent Thrombosis)\n- **ì›ì¸:** ìŠ¤í…íŠ¸ ì‚½ì… í›„ **ì´ì¤‘ í•­í˜ˆì†ŒíŒì œ(DAPT)**ë¥¼ ì¡°ê¸°ì— ì¤‘ë‹¨í–ˆì„ ë•Œ ë°œìƒ.\n- **ê¸°ì „:** ìŠ¤í…íŠ¸ëŠ” ì´ë¬¼ì§ˆì´ë¯€ë¡œ í”¼ê°€ ì—‰ê²¨ ë¶™ìœ¼ë ¤ í•¨(í”¼ë–¡/í˜ˆì „). ì•½ì„ ëŠìœ¼ë©´ ë°”ë¡œ í˜ˆì „ì´ ìƒê²¨ í˜ˆê´€ì„ ë§‰ìŒ.\n- **ê²°ê³¼:** ê¸‰ì„± ì‹¬ê·¼ê²½ìƒ‰(STEMI).\n- **Key Question:** \"ì•½ì„ ì–¼ë§ˆë‚˜ ì˜¤ë˜ ë¨¹ì—ˆëŠ”ê°€?\" (12ê°œì›” ìœ ì§€ ì¤‘ìš”).\n### B. ì¸ê³µ íŒë§‰ í˜ˆì „ì¦ & ê¸°ê³„ íŒë§‰\n- **í•„ìˆ˜ ì•½ë¬¼:** ì™€íŒŒë¦°(Warfarin/Coumadin) í‰ìƒ ë³µìš©.\n- **ìœ„í—˜ì„± ê· í˜•:**\n- í•­ì‘ê³ ì œ ë„ˆë¬´ ì•½í•¨ íŒë§‰ì— í˜ˆì „ ë‚Œ íŒë§‰ ì•ˆ ì›€ì§ì„(í˜‘ì°©/íì‡„) or ë‡Œì¡¸ì¤‘.\n- í•­ì‘ê³ ì œ ë„ˆë¬´ ê°•í•¨ ë‡Œì¶œí˜ˆ ë“± ì¶œí˜ˆ ìœ„í—˜.\n---\n## 5. ìœ ì „ë³‘ê³¼ ì§€ë¦„ê¸¸ì˜ ë¬¸ì œ: HHT (Osler-Weber-Rendu) ğŸ©¸\n### A. ìœ ì „ì„± ì¶œí˜ˆì„± ëª¨ì„¸í˜ˆê´€ í™•ì¥ì¦ (HHT)\n- **í•µì‹¬ ê°œë…:** **ë™ì •ë§¥ ê¸°í˜• (AVM)**. ëª¨ì„¸í˜ˆê´€ ì—†ì´ ë™ë§¥ê³¼ ì •ë§¥ì´ ë°”ë¡œ ì—°ê²°ë˜ëŠ” 'ì§€ë¦„ê¸¸(Shortcut)'ì´ ìƒê¹€.\n- **ì¦ìƒ:**\n- ë°˜ë³µì ì¸ ì½”í”¼ (Epistaxis).\n- í”¼ë¶€ì˜ ë¶‰ì€ ë°˜ì  (Telangiectasia).\n- ìœ„ì¥ê´€ ì¶œí˜ˆ (ì² ê²°í•ì„± ë¹ˆí˜ˆ).\n- **â˜… ì¹˜ëª…ì  í•©ë³‘ì¦: ë‡Œë†ì–‘ (Brain Abscess) & ë‡Œì¡¸ì¤‘**\n- **ê¸°ì „:** í(Lung)ëŠ” ì›ë˜ í˜ˆì „ì´ë‚˜ ì„¸ê· ì„ ê±¸ëŸ¬ì£¼ëŠ” **í•„í„°(Filter)** ì—­í• ì„ í•¨.\n- **í ë™ì •ë§¥ ê¸°í˜• (Pulmonary AVM):** íì˜ í•„í„°ë¥¼ ê±°ì¹˜ì§€ ì•ŠëŠ” 'ì§€ë¦„ê¸¸'ì´ ì¡´ì¬.\n- ë‹¤ë¦¬ ì •ë§¥ì˜ í˜ˆì „ì´ë‚˜ í˜ˆë¥˜ ì† ì„¸ê· ì´ í í•„í„°ë¥¼ ìš°íšŒ **ì¢Œì‹¬ë°© ëŒ€ë™ë§¥ ë‡Œ**ë¡œ ì§í–‰.\n- **ê²°ê³¼:** ë‡Œê²½ìƒ‰(Stroke) ë˜ëŠ” ë‡Œë†ì–‘(Brain Abscess).\n- **ì—°ê²°ê³ ë¦¬:** **\"ì½”í”¼ê°€ ì¦ì€ í™˜ìê°€ ë‡Œë†ì–‘/ë‡Œì¡¸ì¤‘ìœ¼ë¡œ ì™”ë‹¤?\"** **HHT (í AVM)** ì˜ì‹¬!","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-240","focus_area":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","tags":["usmle-step2","core","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"---\n## 6. ë§ˆì§€ë§‰ í€´ì¦ˆ (The Challenge) ğŸ§\n- **ìƒí™©:** ìš´ë™ ì¤‘ ì‘ê¸‰ì‹¤ì— ì˜¨ 17ì„¸ ë†êµ¬ ì„ ìˆ˜. 2ëª….\n- **í™˜ì 1 (AAOCA):** ëŒ€ë™ë§¥ê³¼ íë™ë§¥ ì‚¬ì´ì— ë¼ì–´ ê´€ìƒë™ë§¥ì´ ëˆŒë¦¼. (êµ¬ì¡°ì  í˜ˆê´€ ë¬¸ì œ)\n- **í™˜ì 2 (HOCM, ë¹„í›„ì„± ì‹¬ê·¼ë³‘ì¦):** ìœ ì „ì ìœ¼ë¡œ ì‹¬ì¥ ê·¼ìœ¡ì´ ë‘êº¼ì›Œì ¸ì„œ í”¼ê°€ ë‚˜ê°€ëŠ” ê¸¸(ìœ ì¶œë¡œ)ì´ ë§‰í˜.\n- **ì§ˆë¬¸:** ì´ ë‘ í™˜ìë¥¼ êµ¬ë³„í•˜ê¸° ìœ„í•œ ê²°ì •ì ì¸ **ë³‘ë ¥ ì²­ì·¨ ì§ˆë¬¸**ê³¼ **ì‹ ì²´ ì§„ì°° ë‹¨ì„œ**ëŠ” ë¬´ì—‡ì¼ê¹Œ? (ì‹¬ì¥ ì¡ìŒì˜ ì°¨ì´ ë“± ìƒê°í•´ë³´ì„¸ìš”!)\n---\n# ğŸ”¥ Rapid Fire Recap: High Yield Summary\nì˜¤ë””ì˜¤ ê°•ì˜ ë‚´ìš©ì„ ë°”íƒ•ìœ¼ë¡œ í•œ ì´ˆì••ì¶• ìš”ì•½ì…ë‹ˆë‹¤.\n1. **ì „ì¡°ì¦ìƒ(Prodrome) ìˆëŠ” ì‹¤ì‹ ** **ë¯¸ì£¼ì‹ ê²½ì„± ì‹¤ì‹  (Vasovagal)** **ë¬¼ë¦¬ì  ì €í•­ ìš´ë™ (Counterpressure maneuver)** êµìœ¡.\n2. **ì Šì€ ì„ ìˆ˜ + ìš´ë™ ì¤‘ ì‹¤ì‹ /ê¸‰ì‚¬** **AAOCA** ëŒ€ë™ë§¥/íë™ë§¥ ì‚¬ì´ ê´€ìƒë™ë§¥ ëˆŒë¦¼ (êµ¬ì¡°ì ).\n3. **ì €í˜ˆì•• + JVD + ì‹¬ìŒ ê°ì†Œ (Beck's Triad)** **ì‹¬ì¥ ëˆŒë¦¼ì¦ (Tamponade)** **ê¸°ì´ë§¥ (Pulsus Paradoxus > 10mmHg)** í™•ì¸.\n4. **ìŠ¤í…íŠ¸ ì‹œìˆ  í™˜ì + DAPT ì¡°ê¸° ì¤‘ë‹¨** ê°€ìŠ´ í†µì¦ **ìŠ¤í…íŠ¸ í˜ˆì „ì¦ (STEMI)**.\n5. **ë°˜ë³µë˜ëŠ” ì½”í”¼ + ë‡Œë†ì–‘(Brain Abscess)** **HHT (Osler-Weber-Rendu)** í ë™ì •ë§¥ ê¸°í˜•(AVM)ì´ í•„í„° ì—­í•  ëª»í•¨.\n\"ì•ˆë…•í•˜ì„¸ìš”, USMLE Step 2 ì‹œí—˜ ì¤€ë¹„ë¥¼ ìœ„í•´ ë³´ë‚´ì£¼ì‹  ì†Œì•„ ì‹¬ì¥í˜ˆê´€ íŒŒíŠ¸ ë…¸íŠ¸, ë“œë””ì–´ í¼ì³ë³´ê²Œ ëë„¤ìš”. ì–‘ì´ ì •ë§ ìƒë‹¹í•œë°, ì˜¤ëŠ˜ ì €í¬ì˜ ë¯¸ì…˜ì€ ì´ ì¤‘ì—ì„œ ê°€ì¥ í—·ê°ˆë¦¬ë©´ì„œë„ ë˜ ì‹œí—˜ì— ìì£¼ ë‚˜ì˜¤ëŠ” í•µì‹¬ ì§ˆí™˜ ë„¤ ê°€ì§€, ì´ê±¸ ì™„ë²½í•˜ê²Œ ì •ë³µí•˜ëŠ” ê²ë‹ˆë‹¤. ë„¤. ì‹¬ì‹¤ì¤‘ê²©ê²°ì†, VSDì£ . ê·¸ë¦¬ê³  ì‚¼ì²œíŒíì‡„ì¦, ì‹ ìƒì•„ ì§€ì†ì„± íê³ í˜ˆì••, ë§ˆì§€ë§‰ìœ¼ë¡œ ì¢Œì‹¬í˜•ì„±ë¶€ì „ì¦í›„êµ°. ì´ ë„¤ ê°€ì§€ì— í•œë²ˆ ì§‘ì¤‘í•´ì„œ íŒŒê³ ë“¤ì–´ ë³´ì£ .\"\n---\n# ğŸ©º **Pediatric Cardiology: ì²­ìƒ‰ì¦ ì•„ê¸°(Cyanotic Baby)ì™€ 4ê°€ì§€ í•µì‹¬ ì§ˆí™˜ ì •ë³µ**\nì´ ê°•ì˜ë¡ì€ íŒŸìºìŠ¤íŠ¸ ë‚´ìš©ì„ ê¸°ë°˜ìœ¼ë¡œ USMLE Step 2 ì‹œí—˜ì— í•„ìˆ˜ì ì¸ **ì†Œì•„ ì‹¬ì¥ ì§ˆí™˜ 4ê°€ì§€(VSD, Tricuspid Atresia, PPHN, HLHS)**ë¥¼ ë‹¤ë£¹ë‹ˆë‹¤. ì„ìƒ í˜„ì¥ì—ì„œ 'íŒŒë€ ì•„ê¸°'ë¥¼ ë§Œë‚¬ì„ ë•Œì˜ ëŒ€ì²˜ë²•ë¶€í„° ê° ì§ˆí™˜ì˜ ê²°ì •ì  ë‹¨ì„œ(Clue)ë¥¼ ì •ë¦¬í–ˆìŠµë‹ˆë‹¤.\n## 1. Introduction: ì²­ìƒ‰ì¦(Cyanosis)ì˜ ì›ì¸ì„ ì°¾ì•„ë¼! ğŸ•µï¸â€â™‚ï¸\nì‘ê¸‰ì‹¤ì—ì„œ ì•„ê¸°ê°€ íŒŒë—ê²Œ ë³´ì¼ ë•Œ(Cyanosis), ì´ê²ƒì´ **í(Lung)** ë¬¸ì œì¸ì§€ **ì‹¬ì¥(Heart)** ë¬¸ì œì¸ì§€ êµ¬ë¶„í•˜ëŠ” ê²ƒì´ ê°€ì¥ ì²« ë²ˆì§¸ ê³¼ì œì…ë‹ˆë‹¤.\n### ğŸ§ª í•µì‹¬ ê°ë³„ë²•: ê³ ë†ë„ ì‚°ì†Œ ê²€ì‚¬ (Hyperoxia Test)\n- **ë°©ë²•:** ì•„ê¸°ì—ê²Œ 100% ì‚°ì†Œë¥¼ ê³µê¸‰í•´ë³¸ë‹¤.\n- **í ë¬¸ì œ (Lung Issue):** ì‚°ì†Œë¥¼ ì£¼ë©´ ì‚°ì†Œí¬í™”ë„ê°€ ì­‰ ì˜¬ë¼ê°„ë‹¤. (í ê¸°ëŠ¥ì´ ë–¨ì–´ì ¸ì„œ ì‚°ì†Œ êµí™˜ì´ ì•ˆ ë˜ë˜ ê²ƒì´ ê³ ë†ë„ ì‚°ì†Œë¡œ í•´ê²°ë¨)\n- **ì‹¬ì¥ ë¬¸ì œ (Heart Issue):** â˜… **ì‚°ì†Œë¥¼ ì¤˜ë„ ì‚°ì†Œí¬í™”ë„ê°€ í¬ê²Œ ì˜¤ë¥´ì§€ ì•ŠëŠ”ë‹¤.**\n- **ì´ìœ :** ì‹¬ì¥ ë‚´ë¶€ì˜ **Shunt(ë‹¨ë½)** ë•Œë¬¸ì—, ì´ë¯¸ ì‚°ì†Œê°€ ì—†ëŠ” í”¼(ì •ë§¥í˜ˆ)ê°€ ì‚°ì†Œê°€ ìˆëŠ” í”¼(ë™ë§¥í˜ˆ)ì™€ ì„ì—¬ì„œ ì „ì‹ ìœ¼ë¡œ ë‚˜ê°€ê¸° ë•Œë¬¸. ì•„ë¬´ë¦¬ íì— ì‚°ì†Œë¥¼ ì¤˜ë„ ì„ì¸ í”¼ ìì²´ì˜ ë¬¸ì œëŠ” í•´ê²°ë˜ì§€ ì•ŠìŒ.\në§ì€ ì„ ì²œì„± ì‹¬ì¥ë³‘ ì•„ê¸°ë“¤ì€ íƒœì•„ ì‹œì ˆ ì—´ë ¤ìˆë˜ ë™ë§¥ê´€(PDA) ë•ë¶„ì— ìƒëª…ì„ ìœ ì§€í•©ë‹ˆë‹¤. ì´ ë™ë§¥ê´€ì´ ì¶œìƒ í›„ ë‹«íˆë©´ ì¹˜ëª…ì ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ì´ë¥¼ ë§‰ì•„ì£¼ëŠ” ê²ƒì´ ë°”ë¡œ Prostaglandin(í”„ë¡œìŠ¤íƒ€ê¸€ë€ë”˜) ì…ë‹ˆë‹¤. (ì•½ë¬¼: PGE1)\n## 2. ì‹¬ì‹¤ì¤‘ê²©ê²°ì† (VSD: Ventricular Septal Defect) ğŸ•³ï¸\nì¢Œì‹¬ì‹¤ê³¼ ìš°ì‹¬ì‹¤ ì‚¬ì´ ë²½ì— êµ¬ë©ì´ ë‚œ ìƒíƒœì…ë‹ˆë‹¤. ê°€ì¥ í”í•œ ì„ ì²œì„± ì‹¬ì¥ ì§ˆí™˜ì…ë‹ˆë‹¤.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-260","focus_area":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","tags":["usmle-step2","core"]}
{"chunk_type":"transcript_chunk","text":"### ğŸ“¢ The Paradox of Size (í¬ê¸°ì™€ ì†Œë¦¬ì˜ ì—­ì„¤) â˜…\nì‹œí—˜ì—ì„œ ê°€ì¥ ìì£¼ ë‚˜ì˜¤ëŠ” í•¨ì •ì…ë‹ˆë‹¤.\n| êµ¬ë¶„ | êµ¬ë© í¬ê¸° (Size) | ì¡ìŒ í¬ê¸° (Murmur) | ì¦ìƒ (Symptoms) | ë¹„ìœ  (Analogy) |\n| --- | --- | --- | --- | --- |\n| **Small VSD** | ì‘ìŒ | **ì•„ì£¼ í¼ & ê±°ì¹¨ (Loud & Harsh)** | **ì—†ìŒ (Asymptomatic)** | ì¢ì€ í˜¸ìŠ¤ ëì„ ëˆŒë €ì„ ë•Œ ë¬¼ì´ ì‰­! í•˜ê³  ì„¸ê²Œ ë‚˜ê° ğŸš¿ |\n| **Large VSD** | í¼ | ì‘ê±°ë‚˜ ë¶€ë“œëŸ¬ì›€ | **ì‹¬ê°í•¨ (Heart Failure)** | ë„“ì€ í˜¸ìŠ¤ì—ì„œ ë¬¼ì´ ì¡°ìš©íˆ íë¦„ ğŸŒŠ |\n- **Small VSD:** êµ¬ë©ì´ ì‘ì•„ ì••ë ¥ ì°¨ì´ë¡œ ì¸í•´ í˜ˆë¥˜ ì†ë„ê°€ ë¹¨ë¼ì ¸ ì†Œë¦¬ê°€ ìš”ë€í•¨. (ì¡ìŒì´ í¬ë‹¤ê³  ë³‘ì´ ì‹¬í•œ ê²Œ ì•„ë‹˜!)\n- **Large VSD:** ì••ë ¥ ì°¨ì´ê°€ ê±°ì˜ ì—†ì–´ ì†Œë¦¬ëŠ” ì‘ì§€ë§Œ, í˜ˆë¥˜ëŸ‰ì´ ë„ˆë¬´ ë§ì•„ **íê³¼ìˆœí™˜(Lung flooding)** ë° **ì‹¬ë¶€ì „(Heart Failure)** ë°œìƒ.\n- **ì¦ìƒ:** ì•„ê¸°ê°€ ìˆ¨ì°¨í•˜ê³ , ì –ì„ ì˜ ëª» ë¨¹ê³ (Sucking difficulty), ì²´ì¤‘ì´ ì•ˆ ëŠ˜ê³ , ë•€ì„ í˜ë¦¼.\n- **ì¹˜ë£Œ:**\n- ì‹¬ë¶€ì „ ì¦ìƒì´ ìˆìœ¼ë©´: ì´ë‡¨ì œ(Diuretics)ë¡œ íì˜ ë¬¼ì„ ë¹¼ì¤Œ + ê³ ì—´ëŸ‰ ë¶„ìœ .\n- ê·¸ë˜ë„ ì•ˆ ë˜ë©´: ìˆ˜ìˆ ë¡œ ë§‰ì•„ì¤Œ.\n---\n## 3. ì‚¼ì²œíŒíì‡„ì¦ (Tricuspid Atresia) ğŸš«\nìš°ì‹¬ë°©ê³¼ ìš°ì‹¬ì‹¤ ì‚¬ì´ì˜ ë¬¸(ì‚¼ì²œíŒ)ì´ ì•„ì˜ˆ ë§Œë“¤ì–´ì§€ì§€ ì•Šì€ ë³‘ì…ë‹ˆë‹¤. í”¼ê°€ ìš°ì‹¬ì‹¤ë¡œ ê°ˆ ê¸¸ì´ ë§‰í˜€ë²„ë ¸ìŠµë‹ˆë‹¤.\n- **ìƒì¡´ ì¡°ê±´:** ìš°íšŒë¡œê°€ ë°˜ë“œì‹œ 2ê°œ í•„ìš”í•¨.\n1. **ASD (ì‹¬ë°©ì¤‘ê²©ê²°ì†):** ìš°ì‹¬ë°© â†’ ì¢Œì‹¬ë°©ìœ¼ë¡œ í”¼ê°€ ë„˜ì–´ê°€ì•¼ í•¨.\n2. **VSD (ì‹¬ì‹¤ì¤‘ê²©ê²°ì†):** ì¢Œì‹¬ì‹¤ â†’ ìš°ì‹¬ì‹¤(ì‘ê²Œ í‡´í™”ë¨) â†’ íë¡œ í”¼ë¥¼ ë³´ë‚´ì•¼ í•¨.\n- **ì£¼ìš” íŠ¹ì§•:** ìš°ì‹¬ì‹¤(RV)ì´ í•  ì¼ì´ ì—†ì–´ ë§¤ìš° ì‘ì•„ì§ (Hypoplastic RV). ëŒ€ì‹  ì¢Œì‹¬ì‹¤(LV)ì´ ëª¨ë“  ì¼ì„ ë„ë§¡ì•„ í•¨.\n### âš¡ï¸ ê²°ì •ì  ë‹¨ì„œ (The Key Clue): ECG (ì‹¬ì „ë„) â˜…\n- ì‹ ìƒì•„ëŠ” ì›ë˜ ìš°ì‹¬ì‹¤ì´ ìš°ì„¸í•´ì„œ **ìš°ì¶• í¸ìœ„(Right Axis Deviation)**ë¥¼ ë³´ì´ëŠ” ê²Œ ì •ìƒ.\n- í•˜ì§€ë§Œ ì‚¼ì²œíŒíì‡„ì¦ì€ ìš°ì‹¬ì‹¤ì´ ì‘ê³  ì¢Œì‹¬ì‹¤ì´ ë©”ì¸ì´ë¯€ë¡œ **ì¢Œì¶• í¸ìœ„(Left Axis Deviation, LAD)**ê°€ ë‚˜íƒ€ë‚¨.\n- **ê³µì‹:** **íŒŒë€ ì•„ê¸°(Cyanosis) + ì‹¬ì „ë„ìƒ ì¢Œì¶• í¸ìœ„(LAD) = ì‚¼ì²œíŒíì‡„ì¦ (Tricuspid Atresia)**\n---\n## 4. ì‹ ìƒì•„ ì§€ì†ì„± íê³ í˜ˆì•• (PPHN) ğŸ«\nêµ¬ì¡°ì  ê¸°í˜•(êµ¬ë© ë“±)ì€ ì—†ëŠ”ë°, ê¸°ëŠ¥ì ìœ¼ë¡œ íí˜ˆê´€ì´ í´ì§€ì§€ ì•Šì•„ ë°œìƒí•˜ëŠ” ë¬¸ì œì…ë‹ˆë‹¤.\n- **ìƒí™©:** íƒœì•„ ë•ŒëŠ” íë¡œ ìˆ¨ì„ ì•ˆ ì‰¬ë‹ˆ íí˜ˆê´€ ì €í•­ì´ ë†’ìŒ. íƒœì–´ë‚˜ë©´ íê°€ í´ì§€ë©° ì €í•­ì´ ëš ë–¨ì–´ì ¸ì•¼ í•˜ëŠ”ë°, **ë†’ì€ ì €í•­ì´ ê·¸ëŒ€ë¡œ ìœ ì§€(Persistent)** ë˜ëŠ” ìƒíƒœ.\n- **ê²°ê³¼:** íë¡œ í”¼ê°€ ëª» ê°€ë‹ˆ, í”¼ê°€ ìš°ì‹¬ë°© â†’ ë‚œì›ê³µ(PFO) or ë™ë§¥ê´€(PDA) â†’ ì „ì‹ ìœ¼ë¡œ ë°”ë¡œ ë¹ ì ¸ë‚˜ê° (Right to Left Shunt).\n- **ì›ì¸:** íƒœë³€ í¡ì¸(Meconium aspiration), íë ´ ë“± íê°€ ì•„í”ˆ ê²½ìš°.\n### ğŸ” ì§„ë‹¨ í•µì‹¬: ì‚°ì†Œ í¬í™”ë„ ì°¨ì´ (Pre vs Post-ductal) â˜…\n- **Pre-ductal (ë™ë§¥ê´€ ì „):** **ì˜¤ë¥¸ì†** (ì‹¬ì¥ì—ì„œ ë°”ë¡œ ë‚˜ê°€ëŠ” ê¹¨ë—í•œ í”¼ ë°˜ì˜)\n- **Post-ductal (ë™ë§¥ê´€ í›„):** **ë°œ** (ë™ë§¥ê´€ì„ í†µí•´ ë„˜ì–´ì˜¨ ì •ë§¥í˜ˆì´ ì„ì¸ í”¼)\n- **ì§„ë‹¨ ê¸°ì¤€:** ì˜¤ë¥¸ì†ê³¼ ë°œì˜ ì‚°ì†Œ í¬í™”ë„ ì°¨ì´ê°€ **10% ì´ìƒ** ë‚˜ë©´, ë™ë§¥ê´€ì„ í†µí•œ ìš°ì¢Œë‹¨ë½(Râ†’L shunt)ì´ ìˆë‹¤ëŠ” ëœ» = **PPHN ê°•ë ¥ ì‹œì‚¬**.\n### ğŸ’Š ì¹˜ë£Œ (Treatment)\n- ëª©í‘œ: íí˜ˆê´€ì„ í™•ì¥ì‹œì¼œ ì €í•­ì„ ë‚®ì¶”ëŠ” ê²ƒ.\n- **í•µì‹¬ ì•½ë¬¼:** **í¡ì… ì‚°í™”ì§ˆì†Œ (Inhaled Nitric Oxide, iNO)** â†’ íí˜ˆê´€ë§Œ ì„ íƒì ìœ¼ë¡œ í™•ì¥ì‹œí‚´.\n---\n## 5. ì¢Œì‹¬í˜•ì„±ë¶€ì „ì¦í›„êµ° (HLHS: Hypoplastic Left Heart Syndrome) ğŸ’”\nê°€ì¥ ì‹¬ê°í•˜ê³  ì‘ê¸‰ì¸ ìƒí™©ì…ë‹ˆë‹¤. ì‹¬ì¥ì˜ ì™¼ìª½ ì—”ì§„(ì¢Œì‹¬ì‹¤, ìŠ¹ëª¨íŒ, ëŒ€ë™ë§¥)ì´ ì œëŒ€ë¡œ ë°œë‹¬í•˜ì§€ ì•Šì€ ìƒíƒœì…ë‹ˆë‹¤.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-280","focus_area":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","tags":["usmle-step2","core","treatment","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"- **ë¬¸ì œì :** ì¢Œì‹¬ì‹¤ì´ íŒí”„ì§ˆì„ ëª» í•˜ë‹ˆ ì „ì‹ ìœ¼ë¡œ í”¼ë¥¼ ë³´ë‚¼ ìˆ˜ê°€ ì—†ìŒ.\n- **ìœ ì¼í•œ ìƒëª…ì¤„:** **ìš°ì‹¬ì‹¤** í•˜ë‚˜ë¡œ ë²„íŒ€.\n- ê²½ë¡œ: ìš°ì‹¬ì‹¤ â†’ íë™ë§¥ â†’ **ë™ë§¥ê´€(PDA)** â†’ ëŒ€ë™ë§¥ â†’ ì „ì‹ .\n- ì¦‰, **PDA(ë™ë§¥ê´€)**ê°€ ì—´ë ¤ ìˆì–´ì•¼ë§Œ ì „ì‹ ì— í”¼ê°€ ê°.\n### ğŸš¨ ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤ (The Nightmare Scenario)\n- **ì¶œìƒ ì§í›„:** ë™ë§¥ê´€ì´ ì—´ë ¤ ìˆì–´ì„œ ì•„ê¸°ê°€ ê´œì°®ì•„ ë³´ì„ (Pink baby).\n- **ìƒí›„ 2~3ì¼ ë’¤:** ë™ë§¥ê´€ì´ ìì—°ì ìœ¼ë¡œ ë‹«íˆê¸° ì‹œì‘í•¨.\n- **ì¦ìƒ:** ê°‘ìê¸° **ì‡¼í¬(Shock)**, ì°½ë°±í•´ì§, ë§¥ë°• ë§Œê²¨ì§€ì§€ ì•ŠìŒ, ëŒ€ì‚¬ì„± ì‚°ì¦(Acidosis).ìˆ˜ë„ê¼­ì§€ê°€ ì ê¸´ ê²ƒê³¼ ê°™ìŒ.\n- **ì²­ì§„:** ì‹¬ì¡ìŒ(Murmur)ì€ ëšœë ·í•˜ì§€ ì•ŠìŒ (ë‹¨ì¼ ì œ2ì‹¬ìŒ).\n### ğŸš‘ ì‘ê¸‰ ì²˜ì¹˜ (Key Action) â˜…\n- ì§„ë‹¨ì´ í™•ì •ë˜ê¸° ì „ì´ë¼ë„ ì˜ì‹¬ë˜ë©´ ë°”ë¡œ íˆ¬ì—¬í•´ì•¼ í•¨.\n- **Prostaglandin E1 (PGE1) íˆ¬ì—¬:** ë‹«í˜€ê°€ëŠ” ë™ë§¥ê´€ì„ ê°•ì œë¡œ ë‹¤ì‹œ ì—´ì–´ í˜ˆë¥˜ë¥¼ í™•ë³´í•´ì•¼ í•¨. (ìƒëª…ì¤„ ì—°ê²°)\n- ì´í›„ ë‹¨ê³„ì  ìˆ˜ìˆ  í•„ìš”.\n---\n# ğŸ”¥ Rapid Fire Recap: Must-Know High Yield Summary\nì‹œí—˜ ì§ì „ ì´ê²ƒë§Œì€ ê¼­ ê¸°ì–µí•˜ì„¸ìš”!\n### 1. VSD (ì‹¬ì‹¤ì¤‘ê²©ê²°ì†)\n- **Trap:** êµ¬ë©ì´ ì‘ì„ìˆ˜ë¡ ì†Œë¦¬ëŠ” ë” í¬ë‹¤! (Small VSD = Loud Murmur).\n- **Clinical:** ì¦ìƒì´ ì—†ìœ¼ë©´ Small, ì‹¬ë¶€ì „(ì„±ì¥ë¶€ì§„, ë•€)ì´ ìˆìœ¼ë©´ Large.\n### 2. Tricuspid Atresia (ì‚¼ì²œíŒíì‡„ì¦)\n- **Equation:** **Cyanosis (ì²­ìƒ‰ì¦) + ECGìƒ LAD (ì¢Œì¶•í¸ìœ„)** = **Tricuspid Atresia**.\n- **Anatomy:** ìš°ì‹¬ì‹¤(RV)ì´ ë§¤ìš° ì‘ìŒ (Hypoplastic).\n### 3. PPHN (ì‹ ìƒì•„ ì§€ì†ì„± íê³ í˜ˆì••)\n- **Diagnostic:** **ì˜¤ë¥¸ì†(Pre) vs ë°œ(Post) SpO2 ì°¨ì´ > 10%**.\n- **Treatment:** **Inhaled Nitric Oxide (iNO)** (íí˜ˆê´€ í™•ì¥).\n### 4. HLHS (ì¢Œì‹¬í˜•ì„±ë¶€ì „ì¦í›„êµ°)\n- **Scenario:** ìƒí›„ 2-3ì¼ ëœ ì•„ê¸°ê°€ ê°‘ìê¸° **ì‡¼í¬(Shock)** & ë§¥ë°• ì†Œì‹¤.\n- **Action:** **Prostaglandin E1 (PGE1)** ì¦‰ì‹œ íˆ¬ì—¬ (Keep the PDA open!).\n- **Key Concept:** ë™ë§¥ê´€(PDA)ì´ ìƒëª…ì¤„(Life-line).\n# ğŸ©º USMLE Step 2: ë¹„ì‹¬ì¥ ìˆ˜ìˆ  ì „ ì‹¬í˜ˆê´€ ìœ„í—˜ í‰ê°€ ë° í•©ë³‘ì¦ (Perioperative Cardiovascular Evaluation)","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-300","focus_area":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","tags":["usmle-step2","core","treatment"]}
{"chunk_type":"transcript_chunk","text":"## 1. Introduction: ê°€ìƒì˜ í™˜ìì™€ í•¨ê»˜í•˜ëŠ” ì—¬ì • ğŸ›¤ï¸\nì´ ê°•ì˜ëŠ” ë°©ëŒ€í•œ ì˜ì‚¬ê²°ì • ìˆœì„œë„(Flow chart)ë¥¼ ë‹¨ìˆœíˆ ë‚˜ì—´í•˜ëŠ” ê²ƒì´ ì•„ë‹ˆë¼, **'ê°€ìƒì˜ í™˜ì'**ê°€ ì§„ë£Œì‹¤ ë¬¸ì„ ì—´ê³  ë“¤ì–´ì™€ ìˆ˜ìˆ ì„ ë°›ê³  ë‚˜ê°ˆ ë•Œê¹Œì§€ì˜ ê³¼ì •ì„ ì‹œë®¬ë ˆì´ì…˜í•˜ë©° ì§„í–‰í•©ë‹ˆë‹¤.\n- **ëª©í‘œ:** ìˆ˜ìˆ  ì „ í‰ê°€(Pre-op eval)ë¶€í„° í•©ë³‘ì¦, ì™¸ìƒ(Trauma)ê¹Œì§€ ë¨¸ë¦¿ì†ì— ëª…í™•í•œ ì§€ë„ë¥¼ ê·¸ë¦¬ëŠ” ê²ƒ.\n- **í•µì‹¬ ì§ˆë¬¸:** \"ë‚´ ì•ì— ìˆëŠ” ì´ í™˜ì, ê³¼ì—° ìˆ˜ìˆ ì„ ê²¬ëŒë‚¼ ì‹¬ì¥ì„ ê°€ì¡ŒëŠ”ê°€?\" ğŸ¤”\n---\n## 2. ìˆ˜ìˆ  ì „ í‰ê°€ì˜ í•µì‹¬ ë„êµ¬: RCRI (ì „íˆ¬ë ¥ ì¸¡ì •ê¸°) ğŸ“Š\nì‹¬ì¥ì´ ìˆ˜ìˆ ì´ë¼ëŠ” ìŠ¤íŠ¸ë ˆìŠ¤ë¥¼ ê²¬ë”œ ìˆ˜ ìˆì„ì§€ ê°€ëŠ í•˜ëŠ” **'ì „íˆ¬ë ¥ ì¸¡ì •ê¸°'**ê°€ ë°”ë¡œ **RCRI (Revised Cardiac Risk Index)**ì…ë‹ˆë‹¤.\n### â˜… RCRI 6ëŒ€ í‰ê°€ í•­ëª© (ë…ë¦½ì  ìœ„í—˜ ì¸ì)\n0~1ì ì€ ì €ìœ„í—˜êµ°, 2ì  ì´ìƒì€ ê³ ìœ„í—˜êµ°ìœ¼ë¡œ ë¶„ë¥˜í•©ë‹ˆë‹¤.\n| í•­ëª© | ìƒì„¸ ë‚´ìš© | ë¹„ê³  |\n| --- | --- | --- |\n| **1. ìˆ˜ìˆ  ìœ í˜•** | ëŒ€ë™ë§¥ ìˆ˜ìˆ  ë“± ê³ ìœ„í—˜ ìˆ˜ìˆ ì¸ì§€ | High-risk surgery |\n| **2. ì‹¬ì¥ ë³‘ë ¥** | í—ˆí˜ˆì„± ì‹¬ì¥ì§ˆí™˜ ë³‘ë ¥ | Ischemic heart disease |\n| **3. ì‹¬ë¶€ì „ ë³‘ë ¥** | ìš¸í˜ˆì„± ì‹¬ë¶€ì „ ë³‘ë ¥ | CHF history |\n| **4. ë‡Œí˜ˆê´€ ë³‘ë ¥** | ë‡Œì¡¸ì¤‘(Stroke)ì´ë‚˜ TIA ë“± | Cerebrovascular disease |\n| **5. ë‹¹ë‡¨ë³‘** | **ì¸ìŠë¦°**ìœ¼ë¡œ ì¹˜ë£Œë°›ëŠ” ë‹¹ë‡¨ë³‘ | â˜… ê²½êµ¬ì•½ ì•„ë‹˜ |\n| **6. ì‹ ì¥ ìˆ˜ì¹˜** | ìˆ˜ìˆ  ì „ **Cr > 2.0 mg/dL** | ë§Œì„± ì‹ ì§ˆí™˜(ì „ì‹  í˜ˆê´€ ìƒíƒœ ëŒ€ë³€) |\n## 3. ìˆ˜ìˆ  ê°€ëŠ¥ ì—¬ë¶€ íŒë‹¨ Flow Chart (ì˜ì‚¬ê²°ì • ë‚˜ë¬´) ğŸŒ³\ní™˜ìê°€ ë¬¸ì„ ì—´ê³  ë“¤ì–´ì™”ì„ ë•Œ ì˜ì‚¬ê°€ ë˜ì ¸ì•¼ í•  3ê°€ì§€ í•µì‹¬ ì§ˆë¬¸ ë‹¨ê³„ì…ë‹ˆë‹¤.\n### Step 1. ì‘ê¸‰ ìˆ˜ìˆ ì¸ê°€? (Emergency?) ğŸš¨\n- **Yes:** í‰ê°€í•  ì‹œê°„ ì—†ìŒ â†’ **ì¦‰ì‹œ ìˆ˜ìˆ ì‹¤ë¡œ ì´ë™ (Go to OR)**\n- **No:** Step 2ë¡œ ì´ë™\n### Step 2. ê¸‰ì„± ê´€ìƒë™ë§¥ ì¦í›„êµ°(ACS) ìƒíƒœì¸ê°€? ğŸ’”\n- **Yes:** ë¶ˆì•ˆì • í˜‘ì‹¬ì¦, ê¸‰ì„± ì‹¬ê·¼ê²½ìƒ‰ ë“± ì§€ê¸ˆ ë‹¹ì¥ ì‹¬ì¥ì´ ìœ„í—˜í•œ ìƒíƒœ.\n- â†’ ì˜ˆì •ëœ ìˆ˜ìˆ ì„ ë¯¸ë£¨ê³  **ì‹¬ì¥ ë¬¸ì œë¶€í„° í•´ê²°** (ì‹¬ì¥ë‚´ê³¼ Consult).\n- **No:** Step 3ë¡œ ì´ë™\n### Step 3. RCRI ì ìˆ˜ & ê¸°ëŠ¥ì  ëŠ¥ë ¥ (METs) í‰ê°€ ğŸƒâ€â™‚ï¸\nê°€ì¥ ë§ì€ í™˜ìê°€ í•´ë‹¹í•˜ëŠ” ë‹¨ê³„ì…ë‹ˆë‹¤. ë‘ ê°€ì§€ë¥¼ í•¨ê»˜ ë´…ë‹ˆë‹¤.\n1. **RCRI ì ìˆ˜:** ìœ„ì—ì„œ ê³„ì‚°í•œ ì ìˆ˜.\n2. **ê¸°ëŠ¥ì  ëŠ¥ë ¥ (Functional Capacity):** **4 METs**ê°€ ê¸°ì¤€.\n- â˜… **4 METsì˜ ì˜ë¯¸:** ê³„ë‹¨ 2ì¸µ(Two flights of stairs)ì„ ì‰¬ì§€ ì•Šê³  ì˜¤ë¥¼ ìˆ˜ ìˆëŠ” ì²´ë ¥.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-320","focus_area":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","tags":["usmle-step2","core","tree"]}
{"chunk_type":"transcript_chunk","text":"**[íŒë‹¨ ê¸°ì¤€]**\n- **Good Condition:** (RCRI < 1ì ) **OR** (ê¸°ëŠ¥ì  ëŠ¥ë ¥ â‰¥ 4 METs)\n- â†’ ìˆ˜ìˆ  ì§„í–‰ ê°€ëŠ¥ (Proceed to surgery).\n- **Bad Condition:** (RCRI â‰¥ 2ì ) **AND** (ê¸°ëŠ¥ì  ëŠ¥ë ¥ < 4 METs)\n- â†’ ì¶”ê°€ ê²€ì‚¬ í•„ìš” (**ì•½ë¬¼ ë¶€í•˜ ê²€ì‚¬** ë“± ê³ ë ¤).\n- â†’ ê²€ì‚¬ ê²°ê³¼ì— ë”°ë¼ ìˆ˜ìˆ  ì—¬ë¶€ í˜¹ì€ ê´€ìƒë™ë§¥ ì¬ê°œí†µìˆ  ì„ í–‰ ì—¬ë¶€ ê²°ì •.\n---\n## 4. íŠ¹ìˆ˜ ìƒí™©ë³„ ì ‘ê·¼ (ì‹¬ì¥ íŒë§‰, ë¶€ì •ë§¥) ğŸ’“\n### A. ì‹¬ì¥ íŒë§‰ ì§ˆí™˜ (Valvular Disease)\n- **ê¸°ì¤€:** ì¦ìƒ ìœ ë¬´(Symptomatic)ì™€ ì¤‘ì¦ë„(Severe)ê°€ í•µì‹¬.\n- **ê´€ë¦¬:** ì¤‘ë“±ë„(Moderate) ì´ìƒì˜ íŒë§‰ ì§ˆí™˜ì´ë©´ì„œ ìˆ¨ì´ ì°¨ê±°ë‚˜ ê°€ìŠ´ í†µì¦ ë“± **ì¦ìƒ**ì´ ìˆë‹¤ë©´?\n- â†’ ë¹„ì‹¬ì¥ ìˆ˜ìˆ ë³´ë‹¤ **íŒë§‰ ìˆ˜ìˆ /ì‹œìˆ ì„ ë¨¼ì €** í•˜ëŠ” ê²ƒì´ ì›ì¹™. âš ï¸\n- *ì˜ˆì™¸:* ì¦ìƒì´ ì—†ëŠ” ê²½ì¦ íŒë§‰ ì§ˆí™˜ì€ ë³´í†µ ì§„í–‰ ê°€ëŠ¥.\n- **Tip:** ìœ„í—˜ë„ íŒë‹¨ì´ ì• ë§¤í•  ë•Œ(ì¤‘ë“±ë„ ì´ìƒ)ëŠ” ìˆ˜ìˆ  ìœ„í—˜ë„ì™€ ì¦ìƒì„ ì €ìš¸ì§ˆí•´ì•¼ í•¨.\n### B. ë¶€ì •ë§¥ (Arrhythmia - ì‹¬ë°©ì„¸ë™ ë“±)\n- **ë‘ ë§ˆë¦¬ í† ë¼ ì¡ê¸°:** â‘  í˜ˆì—­í•™ì  ê´€ë¦¬(Rate/Rhythm control) + â‘¡ í•­ì‘ê³ ì œ ê´€ë¦¬(Anticoagulation).\n- **ìœ„ê¸‰ ìƒí™©:** ì‹¬ë°•ìˆ˜ê°€ ë„ˆë¬´ ë¹ ë¥´ê±°ë‚˜ í˜ˆì••ì´ ë¶ˆì•ˆì •í•˜ë‹¤ë©´?\n- â†’ **ì „ê¸°ì  ì‹¬ìœ¨ë™ ì „í™˜ìˆ  (Cardioversion)** ê³ ë ¤.\n- â†’ ì•ˆì •ì ì´ë¼ë©´ ì•½ë¬¼(ë² íƒ€ì°¨ë‹¨ì œ ë“±) ì¡°ì ˆ.\n- **í•­ì‘ê³ ì œ (Warfarin/DOAC) ê´€ë¦¬ ğŸ©¸:**\n- **ì™¸ì¤„ íƒ€ê¸°:** ì•½ì„ ëŠìœ¼ë©´ í˜ˆì „(Stroke) ìœ„í—˜ â¬†ï¸ vs ê³„ì† ì“°ë©´ ìˆ˜ìˆ  ì¤‘ ì¶œí˜ˆ ìœ„í—˜ â¬†ï¸\n- **í•´ê²°ì±… (Bridging Therapy):**\n- ì™€íŒŒë¦°ì€ ë°˜ê°ê¸°ê°€ ê¸¸ì–´ ìˆ˜ìˆ  3~5ì¼ ì „ ì¤‘ë‹¨ í•„ìš”.\n- **ê³ ìœ„í—˜êµ°(ê¸°ê³„ íŒë§‰, ë‡Œì¡¸ì¤‘ ê³¼ê±°ë ¥ ë“±):** ì•½ì„ ëŠëŠ” ê³µë°±ê¸° ë™ì•ˆ ì‘ìš© ì‹œê°„ì´ ì§§ì€ **í—¤íŒŒë¦°(Heparin)** ì£¼ì‚¬ë¡œ ë‹¤ë¦¬ë¥¼ ë†“ì•„ì¤Œ(Bridging).\n- **ì €ìœ„í—˜êµ°:** ê·¸ëƒ¥ ë©°ì¹  ëŠì—ˆë‹¤ê°€ ìˆ˜ìˆ  í›„ ì¬ê°œ.\n---\n## 5. ìˆ˜ìˆ  ì „ ê²€ì‚¬ì˜ ì„ ë³„ì  ì‹œí–‰ (Pre-op Testing) ğŸ§ª\n\"ëª¨ë“  í™˜ìì—ê²Œ ëª¨ë“  ê²€ì‚¬(Full battery)ë¥¼ ëŒë¦¬ëŠ” ê²ƒì€ ë¹„íš¨ìœ¨ì ì´ë‹¤.\"\n- **ì‹¬ì „ë„ (ECG):** ê´€ìƒë™ë§¥ ì§ˆí™˜ì´ ìˆê±°ë‚˜ ì£¼ìš” ì‹¬ì¥ ì‚¬ê±´ ìœ„í—˜ì´ 1% ì´ìƒì¼ ë•Œë§Œ ê¶Œì¥. (ì Šê³  ê±´ê°•í•˜ë©´ êµ³ì´ X)\n- **í‰ë¶€ X-ray:** ì‹¬í ì§ˆí™˜ì´ ìˆê±°ë‚˜ í˜¸í¡ê¸° ì¦ìƒì´ ìˆì„ ë•Œ, í˜¹ì€ ìˆ˜ìˆ  ë¶€ìœ„ê°€ í‰ë¶€/ìƒë³µë¶€ì¼ ë•Œ.\n- **í˜ˆì•¡ ê²€ì‚¬:**\n- **Hb:** ë¹ˆí˜ˆì´ë‚˜ ëŒ€ëŸ‰ ì¶œí˜ˆ ì˜ˆìƒ ì‹œ.\n- **Coagulation:** ì¶œí˜ˆ ë³‘ë ¥ì´ë‚˜ í•­ì‘ê³ ì œ ë³µìš© ì‹œ.\n- **Creatinine:** ì‹ ì¥ ì§ˆí™˜ í˜¹ì€ íŠ¹ì • ì•½ë¬¼ ë³µìš© ì‹œ.\n---\n## 6. ìˆ˜ìˆ  í›„ í•©ë³‘ì¦ (Post-op Complications) ğŸ¤•\nìˆ˜ìˆ ì€ ì„±ê³µí–ˆì§€ë§Œ ê·¸ ì´í›„ ë°œìƒí•  ìˆ˜ ìˆëŠ” ë¬¸ì œë“¤ì…ë‹ˆë‹¤.\n### A. í‰ê³¨ ë¶„ë¦¬ (Sternal Dehiscence) ğŸ¦´\n- **ìƒí™©:** ê°œí‰ ìˆ˜ìˆ  í›„ í‰ê³¨ì„ ë¬¶ì–´ë†¨ëŠ”ë° ë¼ˆê°€ ë¶™ì§€ ì•Šê³  ë²Œì–´ì§.\n- **ì¦ìƒ:** ê¸°ì¹¨í•˜ê±°ë‚˜ ì›€ì§ì¼ ë•Œ ê°€ìŠ´ì—ì„œ **\"ë”¸ê¹(Click)\"** ì†Œë¦¬ê°€ ë‚¨, í‰ê³¨ì˜ ë¶ˆì•ˆì •í•¨(Instability).\n- **ì§„ë‹¨:** ì‹ ì²´ ì§„ì°°(ë§Œì ¸ë³´ë©´ ë¼ˆê°€ í”ë“¤ë¦¼). ì˜ìƒë³´ë‹¤ ì§„ì°°ì´ ì¤‘ìš”.\n- **ì¹˜ë£Œ:** ì¦‰ì‹œ ìˆ˜ìˆ ì  ê³ ì • í•„ìš” (ê°ì—¼ ìœ„í—˜ ë•Œë¬¸).\n### B. ì‹¬ì¥ë§‰ ì ˆê°œ í›„ ì¦í›„êµ° (Post-pericardiotomy Syndrome) ğŸ”¥\n- **ì‹œê¸°:** ìˆ˜ìˆ  í›„ **1ì£¼ ~ 6ì£¼** ì‚¬ì´ (í‡´ì› í›„ ì™¸ë˜ ì˜¬ ë•Œì¯¤).\n- **ì›ì¸:** ì‹¬ì¥ë§‰ì„ ê±´ë“œë ¤ì„œ ìƒê¸´ ì¼ì¢…ì˜ ìê°€ë©´ì—­/ì—¼ì¦ ë°˜ì‘.\n- **ì¦ìƒ:** ì—´(Fever), í‰í†µ(Pleuritic), ì‹¬ì¥ ë§ˆì°°ìŒ(Friction rub).\n- **ì²­ì§„:** **ì‹¬ë‚­ ë§ˆì°°ìŒ(Pericardial friction rub)** - \"ì‚¬ê°ì‚¬ê°/ë¿Œë“œë“\" ì†Œë¦¬.\n### C. ì‹¬ì¥ ëˆŒë¦¼ì¦ (Cardiac Tamponade) ğŸˆ","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-340","focus_area":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","tags":["usmle-step2","core","treatment"]}
{"chunk_type":"transcript_chunk","text":"- **ìƒí™©:** ì‹¬ë‚­ ì‚¼ì¶œ(Effusion)ì´ ì‹¬í•´ì ¸ ì‹¬ì¥ì„ ê½‰ ëˆ„ë¦„.\n- **ì¦ìƒ (Beck's Triad):** ì €í˜ˆì••, ê²½ì •ë§¥ í™•ì¥(JVD), ë¨¼ ì‹¬ì¥ìŒ(Distant heart sound).\n- **ì‘ê¸‰ ì²˜ì¹˜:** ì¦‰ì‹œ ë°”ëŠ˜ì´ë‚˜ ìˆ˜ìˆ ë¡œ ë¬¼ì„ ë¹¼ì¤˜ì•¼ í•¨.\n---\n## 7. í˜ˆê´€ ì™¸ìƒ (Vascular Trauma) - íŒ”/ë‹¤ë¦¬ ğŸ¦µ\nêµí†µì‚¬ê³  ë“±ìœ¼ë¡œ í˜ˆê´€ ì†ìƒì´ ì˜ì‹¬ë  ë•Œì˜ ëŒ€ì²˜ë²•. **ì‹œê°„ê³¼ì˜ ì‹¸ì›€!**\n### â˜… Hard Signs vs Soft Signs\nì˜ì‚¬ê²°ì •ì´ ì™„ì „íˆ ê°ˆë¦¬ëŠ” ê°€ì¥ ì¤‘ìš”í•œ ê°œë…ì…ë‹ˆë‹¤.\n| êµ¬ë¶„ | ì¦ìƒ (Signs) | ì¡°ì¹˜ (Action) |\n| --- | --- | --- |\n| **Hard Signs**<br> |  |  |\n<br>(í™•ì‹¤í•œ ì†ìƒ ì‹ í˜¸) | â€¢ **ë°•ë™ì„± ì¶œí˜ˆ** (í”¼ê°€ ì†Ÿêµ¬ì¹¨)<br>\n<br>â€¢ **ì ì  ì»¤ì§€ëŠ” í˜ˆì¢…** (Expanding hematoma)<br>\n<br>â€¢ **Thrill** (ì§„ë™) / **Bruit** (ì¡ìŒ)<br>\n<br>â€¢ **6Ps** (ì°½ë°±, í†µì¦, ë§¥ë°• ì†Œì‹¤ ë“±) | **â˜… ì¦‰ì‹œ ìˆ˜ìˆ ì‹¤ (OR)**<br>\n<br>(CT ì°ì„ ì‹œê°„ ì—†ìŒ!) |\n| **Soft Signs**<br>\n<br>(ì• ë§¤í•œ ì‹ í˜¸) | â€¢ ê³¼ê±°ì˜ ì¶œí˜ˆ ë³‘ë ¥<br>\n<br>â€¢ ê³¨ì ˆ ë¶€ìœ„ì™€ í˜ˆê´€ì˜ ê·¼ì ‘ì„±<br>\n<br>â€¢ ë¹„ëŒ€ì¹­ì  ë§¥ë°• (ì•½ê°„ ì•½í•¨)<br>\n<br>â€¢ ì‹ ê²½ ì†ìƒ ë™ë°˜ | **ì˜ìƒ ê²€ì‚¬ ë¨¼ì €**<br>\n<br>(CT Angio, Doppler)<br>\n<br>â†’ í™•ì¸ í›„ ì¹˜ë£Œ ê³„íš |\n### ë‘”ìƒì„± ì‹¬ì¥ ì†ìƒ (Blunt Cardiac Injury)\n- **ìƒí™©:** ìš´ì „ìê°€ í•¸ë“¤ì— ê°€ìŠ´ì„ ì„¸ê²Œ ë¶€ë”ªí˜ (\"ì‹¬ì¥ ë©\").\n- **ìœ„í—˜:** ì‹¬ê·¼ íƒ€ë°•ìƒìœ¼ë¡œ ì¸í•œ **ë¶€ì •ë§¥**, ì‹¬ë¶€ì „.\n- **ì§„ë‹¨/ëª¨ë‹ˆí„°ë§:**\n- **ì‹¬ì „ë„(ECG) ëª¨ë‹ˆí„°ë§:** ë¶€ì •ë§¥ ë°œìƒ ê°ì‹œ (ê°€ì¥ ì¤‘ìš”).\n- **Troponin:** ì‹¬ê·¼ íš¨ì†Œ ìˆ˜ì¹˜ í™•ì¸.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-360","focus_area":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","tags":["usmle-step2","core"]}
{"chunk_type":"transcript_chunk","text":"---\n## ğŸš€ Rapid Fire Recap: High Yield Summary\nì˜¤ë””ì˜¤ ê°•ì˜ì—ì„œ ê°•ì¡°ëœ í•µì‹¬ í¬ì¸íŠ¸ ìš”ì•½ì…ë‹ˆë‹¤.\n1. **RCRI (ì „íˆ¬ë ¥ ì¸¡ì •ê¸°):** 6ê°€ì§€ ìš”ì†Œ ì¤‘ **Cr > 2.0**ê³¼ **ì¸ìŠë¦° ì“°ëŠ” ë‹¹ë‡¨** ë†“ì¹˜ì§€ ë§ ê²ƒ! (0-1ì : Go, 2ì +: Stop & Think).\n2. **Pre-op Algorithm:** ì‘ê¸‰? (Go) â†’ ACS? (Stop) â†’ RCRI â‰¥ 2 & METs < 4? (Test).\n3. **METs Cutoff:** **4 METs** (ê³„ë‹¨ 2ì¸µ ì•ˆ ì‰¬ê³  ì˜¤ë¥´ê¸°). ì´ê±° ë˜ë©´ ì›¬ë§Œí•˜ë©´ ìˆ˜ìˆ  OK.\n4. **ì•½ë¬¼ ê´€ë¦¬ (Anticoagulation):** ê³ ìœ„í—˜êµ°(ê¸°ê³„íŒë§‰)ì€ **Heparin Bridging** í•„ìˆ˜. ì €ìœ„í—˜êµ°ì€ ê·¸ëƒ¥ ì¤‘ë‹¨.\n5. **Sternal Dehiscence:** ìˆ˜ìˆ  í›„ ê°€ìŠ´ì—ì„œ **\"ë”¸ê¹(Click)\"** ì†Œë¦¬ ë‚˜ë©´ ë¼ˆê°€ ì•ˆ ë¶™ì€ ê²ƒ. â†’ ìˆ˜ìˆ ì  ê³ ì •.\n6. **Vascular Trauma:**\n- **Hard Signs** (í”¼ ì½¸ì½¸, ë§¥ë°• ì—†ìŒ, ì»¤ì§€ëŠ” í˜ˆì¢…) â†’ **ë‹¥ì¹˜ê³  ìˆ˜ìˆ ë°© (No CT!)**.\n- **Soft Signs** â†’ **CT/Doppler ê²€ì‚¬**.\n1. **Blunt Cardiac Injury:** ê°€ìŠ´ ë¶€ë”ªí˜ â†’ **ECG ëª¨ë‹ˆí„°ë§** (ë¶€ì •ë§¥ ê°ì‹œê°€ ìµœìš°ì„ ).","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-380","focus_area":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","tags":["usmle-step2","core","diagnosis","tree"]}
{"chunk_type":"transcript_chunk","text":"# LM_gyne 1\n---\n# ğŸ©º USMLE Step 2 CK: High Yield Gynecology Physiology Deep Dive\n**One Line Vibe:** ğŸ©¸ í˜¸ë¥´ëª¬ì˜ íë¦„ì„ ë”°ë¼ê°€ëŠ” ë…¼ë¦¬ì ì¸ \"Life Cycle\" ì—¬í–‰, ë¬´ì§€ì„± ì•”ê¸°ëŠ” ì´ì œ ê·¸ë§Œ!\n**Summary:** ì´ ê°•ì˜ëŠ” ë‹¨ìˆœ ì•”ê¸°ê°€ ì•„ë‹Œ ì—¬ì„±ì˜ ìƒì•  ì£¼ê¸°(Life Cycle) íë¦„ì— ë”°ë¥¸ ìƒë¦¬í•™ì  ë³€í™”ì™€ ë³‘ë¦¬ë¥¼ ë‹¤ë£¹ë‹ˆë‹¤. Pubertyì˜ ìˆœì„œ, Menstrual Cycle ê´€ë ¨ ì§ˆí™˜(PMS, Dysmenorrhea), ê·¸ë¦¬ê³  Menopause ê´€ë¦¬ì™€ Red flag signì¸ Post-menopausal bleedingê¹Œì§€, ì‹œí—˜ì— ìì£¼ ë‚˜ì˜¤ëŠ” í•¨ì •ë“¤ì„ \"Logic\"ìœ¼ë¡œ í’€ì–´ëƒ…ë‹ˆë‹¤.\n---\n## ğŸŒ³ The Big Picture: Gyn Physiology Mental Model\nUSMLEì—ì„œ ì´ íŒŒíŠ¸ëŠ” **Timeline(ë‚˜ì´)**ê³¼ **Symptom Pattern**ì„ ë§¤ì¹­í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤. ì•„ë˜ íŠ¸ë¦¬ë¥¼ ë³´ê³  í˜„ì¬ í™˜ìê°€ ì–´ë””ì— ìœ„ì¹˜í•˜ëŠ”ì§€ íŒŒì•…í•´ë³´ì„¸ìš”.\n```\nGynecology Physiology (Life Cycle Approach)\nâ”‚\nâ”œâ”€â”€ 1. Puberty (The Beginning)\nâ”‚   â”œâ”€â”€ Sequence is King (Boobs -> Pubes -> Grow -> Flow)\nâ”‚   â””â”€â”€ Common Fear: Physiologic Leukorrhea (Normal!)\nâ”‚\nâ”œâ”€â”€ 2. Reproductive Age (The Cycle)\nâ”‚   â”œâ”€â”€ Mood Issues (Luteal Phase)\nâ”‚   â”‚   â”œâ”€â”€ PMS (Milder)\nâ”‚   â”‚   â””â”€â”€ PMDD (Severe, Life disruption) -> SSRI\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Pain Issues (Dysmenorrhea)\nâ”‚       â”œâ”€â”€ Primary: PGF2a excess -> NSAIDs\nâ”‚       â””â”€â”€ Secondary: Structural Pathology\nâ”‚           â”œâ”€â”€ Endometriosis (3Ds)\nâ”‚           â”œâ”€â”€ Adenomyosis (Boggy, Globular)\nâ”‚           â””â”€â”€ Fibroids (Lumpy, Irregular)\nâ”‚\nâ””â”€â”€ 3. Menopause (The End of Cycle)\n    â”œâ”€â”€ Diagnosis: 12 months amenorrhea + High FSH\n    â”œâ”€â”€ Management\n    â”‚   â”œâ”€â”€ Local (GSM): Moisturizer -> Topical Estrogen\n    â”‚   â””â”€â”€ Systemic (Hot flashes): HRT (Uterus? +Progestin!)\n    â”‚\n    â””â”€â”€ â˜… THE RED FLAG: Post-menopausal Bleeding\n        â””â”€â”€ Endometrial CA workup (TVUS -> Biopsy)\n```\n---\n## 1. Introduction: Mental Framework\n- **Why Students Fail:** ê°œë…ì´ ë¶ˆê°€ëŠ¥í•´ì„œê°€ ì•„ë‹ˆë¼, ì••ë°•ê° ì†ì—ì„œ ë””í…Œì¼(Details)ì´ ì„ì´ê¸° ì‰½ê¸° ë•Œë¬¸ì…ë‹ˆë‹¤.\n- **Goal:** êµê³¼ì„œë¥¼ ë‹¤ì‹œ ì½ëŠ” ê²ƒì´ ì•„ë‹ˆë¼, **\"Mental Framework\" (ì‚¬ê³ ì˜ í‹€)**ë¥¼ ë§Œë“œëŠ” ê²ƒ.\n- **Approach:** í™˜ìì˜ **Life Cycle**ì„ ë”°ë¼ê°‘ë‹ˆë‹¤. (Puberty â†’ Cycle Issues â†’ Menopause)\n---\n## 2. Puberty: Sequence & Normal Variants\nì‹œí—˜ì—ì„œ ê°€ì¥ ë¨¼ì € ë–¨ì–´ì§€ëŠ” ë„ë¯¸ë…¸ê°€ ë¬´ì—‡ì¸ì§€ ë¬»ëŠ” ë¬¸ì œê°€ ë‚˜ì˜µë‹ˆë‹¤.\n### ğŸš© The Sequence (ìˆœì„œê°€ ìƒëª…!)\n- **Mnemonic:** **\"Boobs, Pubes, Grow, Flow\"** (ì¡°ê¸ˆ ì´ŒìŠ¤ëŸ½ì§€ë§Œ í™•ì‹¤í•œ ì•”ê¸°ë²•!)\n1. **Breast Development (Thelarche):** â˜… **The very first sign!**\n2. **Pubic Hair (Pubarche/Adrenarche)**\n3. **Growth Spurt (Peak Height Velocity)**\n4. **Menarche (First Period):** ê°€ì¥ ë§ˆì§€ë§‰ ë‹¨ê³„.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-1","focus_area":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","tags":["usmle-step2","core","diagnosis","treatment","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"### âš ï¸ The Growth Trap (í‚¤ ì„±ì¥ í•¨ì •)\n- ë§ì€ ì‚¬ëŒë“¤ì´ \"ìƒë¦¬ ì‹œì‘í•˜ë©´ í‚¤ í°ë‹¤\"ê³  ìƒê°í•˜ì§€ë§Œ, ìƒë¦¬í•™ì ìœ¼ë¡œëŠ” ë°˜ëŒ€ì…ë‹ˆë‹¤.\n- **Fact:** ê°€ì¥ ë¹ ë¥¸ ì„±ì¥(Peak Velocity)ì€ **Menarche ì´ì „**ì— ì¼ì–´ë‚©ë‹ˆë‹¤.\n- **Reason:** ìƒë¦¬ê°€ ì‹œì‘ë  ì¯¤ì´ë©´ Estrogenì´ ì´ë¯¸ ì„±ì¥íŒ(Growth plates)ì„ ë‹«ê¸° ì‹œì‘(Fuse)í–ˆê¸° ë•Œë¬¸ì…ë‹ˆë‹¤.\n- *Exam Tip:* ìƒë¦¬ê°€ ì´ë¯¸ ì‹œì‘ëœ ì—¬í•™ìƒì˜ ë¶€ëª¨ê°€ \"ìš°ë¦¬ ì•„ì´ê°€ ì•ìœ¼ë¡œ í‚¤ê°€ ë§ì´ í´ê¹Œìš”?\"ë¼ê³  ë¬»ëŠ”ë‹¤ë©´? -> **Answer: No.** (Major growth event has passed).\n### ğŸ©º Clinical Scenario: Physiologic Leukorrhea\n- **Scenario:** ì‚¬ì¶˜ê¸° ì†Œë…€(Adolescent girl)ê°€ ì§ˆ ë¶„ë¹„ë¬¼(Vaginal discharge) ë•Œë¬¸ì— ê±±ì •ë˜ì–´ ë‚´ì›.\n- Discharge: White, Odorless, Mucoid (ì ì•¡ì„±).\n- Negative: No itching, No pain, No fever.\n- **Mechanism:** ë°°ë€ ì£¼ê¸° ì¤‘ë°˜(Mid-cycle)ì˜ **Estrogen surge**ë¡œ ì¸í•œ ì •ìƒì ì¸ ë°˜ì‘.\n- **Buzzwords:** \"Profuse, Clear, Thin\" (ë³‘ì ìœ¼ë¡œ ë“¤ë¦´ ìˆ˜ ìˆì§€ë§Œ í˜¸ë¥´ëª¬ì— ì˜í•œ ì •ìƒ ì†Œê²¬).\n- **Treatment:** â˜… **Reassurance** (ì•ˆì‹¬ì‹œí‚¤ê¸°). í•­ìƒì œë‚˜ ì¶”ê°€ ê²€ì‚¬ ë¶ˆí•„ìš”.\n---\n## 3. The Menstrual Cycle Issues\nCycleì´ í™•ë¦½ëœ í›„ ë°œìƒí•˜ëŠ” ë¬¸ì œë“¤ì…ë‹ˆë‹¤. í•µì‹¬ì€ **Timing**ê³¼ **Pathology**ì…ë‹ˆë‹¤.\n### A. Mood Symptoms: PMS vs. PMDD\nì§„ë‹¨ì˜ í•µì‹¬ì€ ì¦ìƒì˜ **Timing**ì…ë‹ˆë‹¤.\n- **Timing Rule:** ì¦ìƒì€ ë°˜ë“œì‹œ **Luteal Phase** (ìƒë¦¬ ì‹œì‘ 1-2ì£¼ ì „)ì— ë‚˜íƒ€ë‚˜ì•¼ í•˜ë©°, **ìƒë¦¬ê°€ ì‹œì‘ë˜ë©´ ì‚¬ë¼ì ¸ì•¼ í•¨ (Symptom-free interval í•„ìˆ˜)**.\n-\n- **PMS (Premenstrual Syndrome):** ì‹ ì²´ì (Bloating, Breast tenderness) + ê°€ë²¼ìš´ ê¸°ë¶„ ë³€í™”(Irritability).\n- **PMDD (Premenstrual Dysphoric Disorder):**\n    - PMSì˜ \"Spicy version\" (Level 11ë¡œ ì¹˜ì†ŸìŒ).\n    - ì¼ìƒ ìƒí™œ íŒŒê´´ (Missing work, fighting with people).\n    - Severe anger & Irritability.\n- **Diagnosis:** **Menstrual Diary** (2ì£¼ê¸° ë™ì•ˆ ê¸°ë¡í•˜ì—¬ íƒ€ì´ë° ì¦ëª…).\n- **Treatment:**\n    - **First Line:** â˜… **SSRIs** (ìš°ìš¸ì¦ë³´ë‹¤ íš¨ê³¼ê°€ ë¹ ë¦„).\n        - *Note:* Luteal phaseì—ë§Œ ë³µìš©í•˜ê±°ë‚˜ ë§¤ì¼ ë³µìš© ê°€ëŠ¥.\n        - *Next step if fails:* OCPs (to suppress ovulation).\n### B. Pain: Dysmenorrhea (ìƒë¦¬í†µ)\n**Primary** (êµ¬ì¡°ì  ì´ìƒ ì—†ìŒ) vs **Secondary** (êµ¬ì¡°ì  ì´ìƒ ìˆìŒ) êµ¬ë³„ì´ ì¤‘ìš”í•©ë‹ˆë‹¤.\n| êµ¬ë¶„ | Primary Dysmenorrhea | Secondary Dysmenorrhea |\n| --- | --- | --- |\n| **íŠ¹ì§•** | Normal Anatomy (ì •ìƒ ê³¨ë°˜ ê²€ì§„) | Structural Pathology (êµ¬ì¡°ì  ë¬¸ì œ) |\n| **ì›ì¸** | Excess **Prostaglandins (PGF2a)** | Endometriosis, Adenomyosis, Fibroids |\n| **ê¸°ì „** | ìê¶ ê·¼ìœ¡ì˜ Ischemic pain (Vasoconstriction) | ë³‘ë³€ì— ì˜í•œ í†µì¦ |\n| **ì¹˜ë£Œ** | **NSAIDs** (First line) | ì›ì¸ ì§ˆí™˜ ì¹˜ë£Œ |\n### ğŸ•µï¸ Secondary Dysmenorrhea: The 3 Main Suspects\nì‹œí—˜ì—ì„œ ë³‘ë ¥ì„ í†µí•´ ì´ ì„¸ ê°€ì§€ë¥¼ êµ¬ë³„í•´ì•¼ í•©ë‹ˆë‹¤.\n1. **Endometriosis (ìê¶ë‚´ë§‰ì¦)**\n- **The 3 Ds:** DysmenorrheağŸ˜§, Deep Dyspareunia (ì„±êµí†µ)ğŸ˜, Dyschezia (ë°°ë³€í†µ - Painful pooping). ğŸ’©\n    - *Pathology:* ìê¶ ë‚´ë§‰ ì¡°ì§ì´ ìê¶ ë°–ì— ì¡´ì¬.\n    - *Exam:* Fixed uterus, Nodules on uterosacral ligament.\n1. **Adenomyosis (ìê¶ì„ ê·¼ì¦)** â˜… **High Yield Terminology ğŸ’**\n- *Pathology:* ìê¶ ë‚´ë§‰ì´ ìê¶ ê·¼ìœ¡ì¸µ(Myometrium)ì„ íŒŒê³ ë“¦.\n- *Exam Keyword:* **\"Boggy\"**, **\"Globular\"**, **\"Tender\"** uterus.\n- *Patient:* ì£¼ë¡œ ë‚˜ì´ê°€ ì¢€ ë” ìˆê³ , ì¶œì‚° ê²½í—˜ì´ ìˆëŠ” ì—¬ì„±(Older, Multiparous).\n- *Symptom:* Heavy bleeding + Pain.\n1. **Fibroids (Leiomyoma, ìê¶ê·¼ì¢…) ğŸª¨**\n- *Exam Keyword:* **\"Irregular\"**, **\"Lumpy\"**, **\"Knobby\"** (ëŒë©©ì´ê°€ ë“  ì£¼ë¨¸ë‹ˆ ëŠë‚Œ).\n- *Comparison:* AdenomyosisëŠ” ì „ì²´ì ìœ¼ë¡œ ë¶€ë“œëŸ½ê²Œ ì»¤ì§„(Uniformly enlarged) ë°˜ë©´, FibroidsëŠ” ìš¸í‰ë¶ˆí‰í•¨.\n- *Diagnosis:* Pelvic Ultrasound.\n---\n## 4. Menopause (The Sunset)","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-21","focus_area":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### ğŸ“‰ Definition & Diagnosis\n- **Definition:** 12ê°œì›” ì—°ì† ë¬´ì›”ê²½ (12 consecutive months of amenorrhea).\n- **Lab:** â˜… **High FSH** (ë‚œì†Œê°€ Estrogenì„ ì•ˆ ë§Œë“œë‹ˆ ë‡Œí•˜ìˆ˜ì²´ê°€ ì†Œë¦¬ì§€ë¦„).\n### ğŸŒ¡ï¸ Management Scenarios\n### Scenario 1: Genitourinary Syndrome of Menopause (GSM)\n- **Symptoms:** Vaginal dryness, Urgency, Recurrent UTIs, Painful sex.\n- **Exam:** Pale mucosa, Narrowed introitus, **pH > 5** (Alkalineí™” ë¨ -> ê°ì—¼ ì·¨ì•½).\n- **Treatment Ladder:**\n    1. **Non-hormonal Moisturizers/Lubricants** (First step).\n    2. If fails -> **Topical (Vaginal) Estrogen**.\n        - *Safety:* ì „ì‹  í¡ìˆ˜ê°€ ë¯¸ë¯¸í•˜ì—¬ ì•ˆì „í•¨.\n### Scenario 2: Systemic Symptoms (Hot Flashes) - HRT Rules\nHot flashes(í˜ˆê´€ìš´ë™ ì¦ìƒ)ê°€ ë„ˆë¬´ ì‹¬í•´ ì‚¶ì˜ ì§ˆì´ ë–¨ì–´ì§ˆ ë•Œ HRT(Hormone Replacement Therapy)ë¥¼ ê³ ë ¤í•©ë‹ˆë‹¤.\n- **Step 1: Contraindications Check (ì ˆëŒ€ ê¸ˆê¸° í™•ì¸)**\n    - Breast Cancer history\n    - Endometrial Cancer history\n    - Blood Clots (DVT/PE)\n    - Active Liver Disease\n        - *Result:* ë§Œì•½ í•˜ë‚˜ë¼ë„ í•´ë‹¹ë˜ë©´ -> **Non-hormonal options (SSRIs like Paroxetine)**.\n- **Step 2: Anatomy Check (ìê¶ì´ ìˆëŠ”ê°€?)** â˜… **CRITICAL**\n    - **Uterus Present (+):** Must give **Estrogen + Progestin**.\n        - *Why?* Unopposed Estrogenì€ ìê¶ë‚´ë§‰ì„ ê³„ì† ì¦ì‹ì‹œì¼œ **Endometrial Cancer**ë¥¼ ìœ ë°œí•¨. Progestinì´ ë‚´ë§‰ì„ ë³´í˜¸(Protect)í•¨.\n    - **No Uterus (Hysterectomy):** Only **Estrogen**. (ë³´í˜¸í•  ë‚´ë§‰ì´ ì—†ìœ¼ë¯€ë¡œ).\n---\n## 5. Post-menopausal Bleeding (The Big Red Flag) ğŸš¨\n- **Rule:** íê²½ í›„ ì¶œí˜ˆì€ **Endometrial Cancer** until proven otherwise. (ë‹¨ í•œ ë²ˆì˜ ì¶œí˜ˆì´ë¼ë„ ë¬´ì‹œ ê¸ˆì§€).\n- **Workup Steps:**\n    1. **Transvaginal Ultrasound (TVUS)**: ìê¶ë‚´ë§‰ ë‘ê»˜(Stripe) ì¸¡ì •.\n    2. **Decision based on Thickness:**\n        - **Stripe <= 4mm:** Low risk -> Observe (Atrophy ê°€ëŠ¥ì„± ë†’ìŒ).\n        - **Stripe > 4mm:** High risk -> **Endometrial Biopsy (Gold Standard)**.\n            - *Note:* ì´ˆìŒíŒŒ ì—†ì´ ë°”ë¡œ Biopsyë¡œ ê°€ëŠ” ê²½ìš°ë„ ë§ìŒ. ì¤‘ìš”í•œ ê±´ **Tissue diagnosis**ê°€ í•„ìš”í•˜ë‹¤ëŠ” ê²ƒ.\n---","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-41","focus_area":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"recap_summary","text":"## ğŸ”¥ Rapid Fire Recap: Must-Know High Yield Summary\nê°•ì˜ ë§ˆì§€ë§‰ì— ì •ë¦¬ëœ \"Golden Rules\" ì…ë‹ˆë‹¤.\n1. **Puberty Sequence:** **Boobs â†’ Pubes â†’ Grow â†’ Flow**. (í‚¤ ì„±ì¥ì€ ìƒë¦¬ ì „ì— í”¼í¬!)\n2. **Physiologic Leukorrhea:** Mid-cycle mucusëŠ” ì •ìƒ(Normal) â†’ **Reassurance**.\n3. **PMS/PMDD Dx:** **Menstrual Diary**ê°€ í•„ìˆ˜ (ì¦ìƒì´ ì—†ëŠ” ê¸°ê°„ì´ ìˆì–´ì•¼ í•¨). TOC SSRI\n4. **Dysmenorrhea:**\n    - Normal Exam = **Primary** (Tx: NSAIDs).\n    - Boggy/Globular Uterus = **Adenomyosis**.\n    - Irregular/Lumpy Uterus = **Fibroids**.\n5. **Menopause HRT:** ìê¶ì´ ìˆìœ¼ë©´(Uterus +) ë°˜ë“œì‹œ **Progestin**ì„ ì„ì–´ë¼! (Estrogen ë‹¨ë… ê¸ˆì§€).\n6. **Post-menopausal Bleeding:** ë¬´ì¡°ê±´ **Endometrial Biopsy** (or TVUS first)ë¡œ ì•”ì„ ë°°ì œí•˜ë¼.\n    - Thin stripe (<=4mm): Observe.\n    - Thick stripe (>4mm): Biopsy.\n---\n# ğŸ§ USMLE Step 2 High-Yield Gyn & Reproductive Health ê°•ì˜ë¡\nì´ ê°•ì˜ëŠ” ë‹¨ìˆœí•œ ì§€ì‹ ì „ë‹¬ì´ ì•„ë‹Œ, ì„ìƒì  íŒë‹¨ì„ ìœ„í•œ **Mental Scaffold(ì‚¬ê³ ì˜ í‹€)**ì™€ **Logic Tree(ë…¼ë¦¬ êµ¬ì¡°)**ë¥¼ êµ¬ì¶•í•˜ëŠ” ê²ƒì„ ëª©í‘œë¡œ í•©ë‹ˆë‹¤. ì‹œí—˜ì—ì„œ ìì£¼ ë“±ì¥í•˜ëŠ” ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤(Vignette)ë¥¼ í•´ê²°í•˜ê¸° ìœ„í•œ ìƒë¦¬í•™ì  ê·¼ê±°ì™€ \"Why\"ì— ì§‘ì¤‘í•©ë‹ˆë‹¤.\n## 1. Introduction: 3 Main Pillars ğŸ›ï¸\nì˜¤ëŠ˜ ê°•ì˜ëŠ” ë°©ëŒ€í•œ ì‚°ë¶€ì¸ê³¼ ë‚´ìš©ì„ ì„¸ ê°€ì§€ í•µì‹¬ ê¸°ë‘¥ìœ¼ë¡œ ì •ë¦¬í•©ë‹ˆë‹¤.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-53","focus_area":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","tags":["usmle-step2","core","recap","diagnosis","treatment","tree"]}
